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ABSTRACT 
Radiation therapy is one of the main modalities used to treat cancers of the lung, 
liver and breast. Respiratory motion during treatment can shift the position of the 
tumour out of the fixed radiation beam, resulting in underdosing of the tumour 
and accidental overdosing of normal tissue. Many strategies for respiratory 
motion management have been developed, such as delineation of an internal 
target volume to capture the range of tumour movement; adaptive radiotherapy 
which tracks the tumour motion by following implanted markers; and respiratory 
gated radiotherapy, where the radiation beam is turned on and off when the 
tumour moves into and out of a known position respectively. In gated treatment, 
the tumour position may be described as a function of the phase or amplitude of 
the breathing cycle.  
 
External surrogates for motion are commonly used in gating, such as spirometry 
or Varian’s Real Time Position ManagementTM system (RPM) which uses a 
reflective marker block, typically positioned on the patient’s chest or abdomen. 
4D imaging studies have demonstrated cases where correlation exists between 
external surrogates and tumour motion. For these systems to be effective, the 
regularity and reproducibility between the initial assessment and subsequent 
treatment fractions are vital. 
 
Not all patients are suitable candidates for gated treatment. Many lung cancer 
sufferers are unable to sustain their breathing in a reproducible pattern intra- and 
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inter-fraction. A method of pre-selecting those patients suitable for respiratory 
gated radiotherapy treatment would minimise patient discomfort during treatment 
and avoid the inefficient use of time and resources. 
 
The aim of this research was to investigate parameters that could quantitatively 
describe the reproducibility of breathing motion, and to determine if one or more 
of these parameters could be used as selection criteria to actively assist the 
clinician in the decision to proceed to 4DCT simulation for treatment planning, 
and gated treatment.  
 
A software tool was developed in MatLab to analyse the breathing tracks 
acquired with a customised spirometer and RPM. A total of 50 breathing tracks of 
60 s duration or greater were obtained from 3 volunteers and 9 patients. These 
tracks were evaluated for intra- and inter-fraction variations. 
 
Five parameters were identified for analysis: mean cyclic baseline (mean value 
between the maximum inhale and exhale), amplitude, frequency and asymmetry; 
a relative duty cycle (the maximum amount of time spent within 20% of the 
maximum inhale and exhale of breathing cycle, relative to breathing frequency) 
was also calculated as a substitute for the true duty cycle at treatment.  
 
The results show that inter-fraction variation is generally larger than intra-fraction 
variation. This indicates that a reference breathing track obtained at the time of 
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4DCT simulation for treatment planning, or at the first treatment fraction, must be 
used with caution as many parameters are not reproducible from fraction to 
fraction. The use of respiratory correlated image guidance with each treatment 
fraction is recommended to minimise the inter-fraction variation. 
 
In general, the volunteers exhibited better intra- and inter-fraction reproducibility 
than the patients. The variation in amplitude for both volunteers and patients 
indicate that amplitude-based gating regimens should be assessed on an 
individual basis. The frequency, baseline and asymmetry parameters may be 
used as indicators of suitability for phase-based gating.  
 
A definitive value for each parameter for patient suitability could be determined 
for a clinical protocol, however many factors must be considered such as the 
patient throughput efficiency, technological limits of the treatment system and an 
individual’s physical tolerance for the treatment technique. However the 
parameters investigated are useful measures that may assist the clinician in 
patient selection for respiratory gated radiotherapy when used in conjunction with 
the requirements, limitations and preferences of the radiotherapy centre and 
patient. 
 17 
1 INTRODUCTION and LITERATURE REVIEW 
External beam radiation therapy is one of the three main modalities used in the 
treatment of cancer. Linear accelerators (linacs) produce an ionising electron or 
photon beam that is directed onto the affected area, with the aim of destroying all 
the abnormal tumour cells whilst sparing as much of the surrounding normal 
tissue as possible (see Figure 1.1). Studies have linked higher radiation doses 
delivered to the tumour with an increase in overall patient survival rates,1 hence 
dose escalation to the tumour is desirable.  
 
Some of many complications in dose escalation lie in the difficulties associated 
with directing the radiation beam to the tumour due to patient movement and 
other physiological considerations. When using radiation therapy to treat 
thoracic, abdominal and pelvic cancers, movements such as breathing can shift 
the position of the tumour from the fixed radiation beam (see Figure 1.2), 
resulting in underdosing of the tumour and overdosing of the surrounding normal 
tissue.2-12 Tumours situated in the lung are particularly susceptible to respiratory 
motion. 
 
Lung cancer is the most common cause of cancer death in Australia and the 
United States.13-15 Small cell and non-small cell lung cancers are the two main 
types of lung cancer. The type of treatment given is dependent on the type of 
cancer and how far it has progressed. A combined modality treatment is usually 
prescribed  for lung cancer, with over 50% of patients receiving radiotherapy.16  
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However the lungs are also physically close to organs at risk, and the healthy 
lung tissue itself needs to be preserved in any radiotherapy treatment regimen. 
Lung tumours are particularly subject to respiratory motion. Studies have shown 
that abdominal tumours may shift up to 35 mm with respiratory motion17 whilst 
shifts up to 50 mm have been cited for lung tumours,11 resulting in a geographical 
miss of the tumour volume. 
 
 
 
 
Figure 1.1 Linear accelerator used to treat a patient. The radiation beam is fixed in position whilst 
the patient is free to breathe normally. Large chest wall and abdominal movements have been 
associated with respiratory motion. (a) The solid line indicates the exhale position of the chest 
wall, and (b) the dashed line indicates the inhale position of the chest wall. Note the difference 
between the two positions relative to the linear accelerator treatment head. 
 
 
Linear accelerator treatment head Radiation beam emerges from treatment head 
(a) 
ac
(b) 
ac
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Figure 1.2 Patient treatment planning image (lateral view) showing the radiation dose to the 
tumour (very faint horizontal lines) with (a) a normal treatment area delineated and (b) chest wall 
motion due to respiratory motion simulated by shifting the treatment field 2 cm anteriorly. The 
treatment area in (b) barely covers the posterior edge of the tumour volume and delivers over 
100% of the radiation dose to the anterior healthy lung tissue.    
 
1.1  RESPIRATORY MOTION MANAGEMENT 
Several methods have been proposed to account for, minimise or manage 
respiratory motion for patients undergoing radiotherapy. These are broadly 
classified as: motion encompassing, motion restraint, motion compensation and 
respiratory gating. 
 
(a) (b) 
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1.1.1 Motion Encompassing 
Increasing the volume for irradiation compensates for a geographical miss by 
encompassing the entire range of motion of the tumour during respiration. An 
internal target volume (ITV) is used to delineate the volume of the full tumour 
excursion,18 with three CT scanning techniques generally used to acquire the 
images for the purposes of delineating an ITV: slow CT scan, breath hold CT and 
4D CT, also known as respiration correlated CT.2  
 
Studies have shown that treatment failure for medically inoperable Stage I non 
small cell lung cancer (NSCLC) can be attributed to local recurrence and tumour 
size,19-20 with higher rates of local control in smaller tumours.21 In a study of 113 
patients given conformal radiation doses of 60 – 72 Gy, Lagerwaard et al found 
that the median survival rate of patients was 20 months, and doses of 70 Gy or 
higher showed correlation with early oesophageal toxicity in nearly 16% of the 
patients.20 This is similar to an earlier study by Cheung et al, who analysed the 
outcomes of 102 patients with early stage NSCLC, with tumour volumes ranging 
from 0.5 cm3 to 143.7 cm3. Radiation doses ranged from 50 Gy to 52.5 Gy. They 
found the median survival was 24 months, with acute oesophagitis in nearly 23% 
of the patients.21 Both studies concluded that higher radiation doses correlates 
with better local control and survival, however this has the adverse effect of 
increasing radiation dosage to the surrounding normal tissue and other radio-
sensitive organs at risk,12,22-26 such as heart, spinal cord, oesophagus and 
healthy lung tissue.27  
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Onimaru et al reported that acute oesophagitis and chronic chest pain in 2 of the 
46 patients studied was radiation induced, and upon investigating the planned 
radiation dose, concluded that the oesophagus was possibly under-contoured 
and the chest wall received an estimated 90% of the prescribed 60 Gy. They 
recommend that consideration of the uncertainty in contouring anatomical 
structures and planning volumes is of critical importance in the setup of patients 
receiving high dose radiotherapy in an image guided setting.28-29 
 
Other studies have since shown that the delineation of an ITV is dependent on 
the ongoing reproducibility of a single CT scanning session, and may not be 
indicative of the internal and external movement and setup during a single 
fraction or over the course of a patient’s treatment.29-32 
 
Many motion management strategies have therefore focussed on the tumour 
motion in one of two ways: physically minimising the tumour motion by 
restraining the patient’s respiratory movement, or compensating for the motion 
using a variety of techniques and a combination of hardware and software. 
 
1.1.2 Motion Restraint 
Physical restraints such as an abdominal compression plate forces the patient to 
breathe shallowly, which minimises the diaphragmatic excursion. Heinzerling et 
al.33 found that a high compression level, which caused patient discomfort, was 
required to reduce tumour motion to <1 cm in all patients. Other studies have 
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found that motion reduction using abdominal compression is not reproducible or 
quantifiably significant.34-35 
 
1.1.3 Motion Compensation 
Respiratory motion compensation has been widely investigated and described in 
the literature.5-8,12-13,16,29,36-45  The AAPM report by Keall et al.2 describes, defines 
and explains respiratory motion and the many techniques used to visualise, 
compensate for and manage this motion in radiation therapy. 
 
Some motion compensation techniques require the patient to actively assist by 
holding their breath after inhaling or exhaling deeply, such as in the Deep 
Inspiration Breath Hold (DIBH) technique;46 or with the assistance of a digital 
spirometer as in Active Breathing Control.9,47 These methods have been found to 
be successful in minimising tumour excursions within a few millimetres.17  
 
Other motion compensation techniques may use breath holding in conjunction 
with another form of motion management, or allow the patient to breathe freely 
whilst the respiratory induced motion is compensated for without the patient’s 
assistance. Many of these techniques rely on fiducial markers implanted into the 
tumour. The markers are visualised through an imaging device such as 
fluoroscopy, and the radiation is delivered based on the recognized fiducial 
positions. Systems such as Mitsubishi’s Real Time Radiation Therapy (RTRT) 
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system (Mitsubishi Electronics, Tokyo, Japan) utilises this method to treat moving 
tumours in real time, also known as 4DRT.48  
4DRT is dependent on the time lag, or latency period, between the system 
recognition of the implanted fiducial, the speed of beam collimation and the linac 
beam on response time. Latency periods as small as 200 ms may cause 
significant dosimetric errors, particularly when used with a predictive method of 
tumour tracking,49 as some predictive algorithms do not take system latency into 
account; resulting in the system lagging behind the predicted tumour location. 
Other predictive algorithms incorporate system latency into the tumour position 
prediction; this allows the geometric errors to be accurately quantified.50 
 
The system is also dependent on the use of several fiducial markers implanted 
into the tumour. The percutaneous marker insertion has been likened to 
transthoracic needle biopsies for lung nodules, which resulted in chest tube 
placements for up to 38% of patients due to pneumothrorax.51,52 However, it has 
been argued that the increase in treatment accuracy due to tracking markers 
implanted in the tumour outweighs the potential morbidity.53 Fiducial migration is 
another disadvantage and may be exacerbated by tumour shrinkage or 
deformation as the radiotherapy treatment progresses, although Shirato et al.48 
have reported stability of the marker positions for up to 4 weeks. 
 
Compounding the disadvantages of implanted fiducial markers is the requirement 
to view them using a radiation producing imaging device such as kV or MV CT, 
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or fluoroscopy. Techniques such as 4DCT are increasingly used to correlate 
respiratory motion to the CT scan and assist in the planning of motion managed 
treatment. This is accomplished by reconstructing the images acquired with 
4DCT in synchrony with the patient’s breathing waveform; several CT series are 
usually acquired for the patient and reconstructed at different phases of inhale 
and exhale.54 The radiation generated by these methods accumulates to clinically 
significant doses, particularly skin dose, to the patient.29,53,55 In the case of 4DCT, 
radiation doses up to 4 times that of helical CT scans have been reported.56  
 
An exception is the Calypso System (Calypso Medical Technologies, Seattle, 
USA) which is one of the only commercially available devices that avoids the 
need for ionising radiation to produce an image. Instead, the positions of 
implanted electromagnetic transponders are detected by a 4D electromagnetic 
array. The system is largely used in prostate motion management,57-59 however 
recent studies have investigated applications in the context of gated 
radiotherapy.60-62 
 
1.1.4 Respiratory Gating 
The first published study of respiratory gating in 1989 described the use of a 
microwave oscillator to start and stop the radiation based on gating signals, with 
the thoracoabdominal pressure measured using airbags. It was concluded that 
for tumours close to the diaphragm, this technique delivered the treatment more 
precisely.63 
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Gated radiotherapy describes the process of turning the radiation beam on and 
off in synchrony with the respiratory motion, analogous to opening and closing a 
gate.64 There are two primary gating thresholds used: phase based gating and 
amplitude based gating. In phase based gating, the radiation beam is turned on 
and off when the calculated breathing cycle enters a pre-determined angular 
phase; whereas in amplitude based gating, the radiation beam is turned on and 
off when the breathing cycle enters a pre-determined displacement position.64 
 
Respiratory gating is dependent on information from the breathing cycle being 
used to control the radiation delivery. Less invasive respiratory motion surrogates 
are often employed in respiratory gating. It is therefore important that the 
relationship between the tumour motion and the corresponding respiratory 
motion surrogate is known and reproducible over time.65-66 
 
Mageras et al.67 positioned a respiratory motion surrogate on six on patients 
receiving radiotherapy for lung cancer, between the xiphoid tip and umbilicus. 
The position was chosen based on a minimum observed amplitude of 5 mm. The 
patients underwent fluoroscopy for approximately 1 min whilst breathing 
normally, then 5 of the patients were asked to follow audio instructions for inhale 
and exhale. They reported that the external surrogate accurately predicted 
internal respiration in most cases. This concurs with a study by Vedam et al.64, 
which concluded that tumours in the liver or lower lobe of the lung have a 
stronger correlation with diaphragmatic motion in the superior-inferior direction.  
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Feng et al.5, however, found little correlation between the tumour position and the 
external movement of the abdominal wall and diaphragm in pancreatic cancers. 
Hence the degree of correlation, and reproducibility, between the tumour motion 
and external respiratory surrogate is limited by the position of the tumour and 
placement of the surrogate.52  
 
Keall et al.2 state that the displacement correlation is not the quantity of interest 
as the surrogate should not be considered a predictor of absolute tumour 
position; rather that the surrogate should be used to determine the phase of the 
breathing motion. However a phase match between the respiratory motion 
surrogate and internal tumour motion should not be assumed, nor considered 
stationary over the course of treatment (inter-fraction).  
 
1.2 EXTERNAL SURROGATES FOR RESPIRATORY MOTION 
Technologies used as external motion surrogates include pressure belts, 
spirometry and infrared position monitoring. The commercially available Anzai 
belt (Anzai Medical, Tokyo, Japan) is positioned around the patient and detects 
the pressure caused by external respiratory motion,12 whereas spirometry directly 
measures the airflow or pressure during inhalation and exhalation. Varian’s Real 
Time Position Management (RPM) system (Varian Medical Systems, Palo Alto, 
USA) is another commercially available technology.  
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RPM uses an infra-red camera to monitor movement of an infra-red reflective 
marker placed on the patient.68 Whilst the spirometer provides a better indication 
of internal tumour motion,69 the RPM system is extremely simple to use, non 
invasive and effortless for breathing impaired patients. Other external surrogates 
that have been investigated include laser displacement sensors70 and 
plethysmography,71 however these are not commonly reported in the literature. 
 
 
1.3 MOTION REPRODUCIBILITY 
The intra- and inter-fraction reproducibility of the tumour motion and respiratory 
motion surrogate are of concern in planning and delivering respiratory gated 
radiotherapy.31,46 Many studies have addressed the issue of intra- and inter-
fraction reproducibility to enable better predictive capabilities of the radiation 
delivery and tumour tracking systems.31,46,54,72-74 Predicting or assuring the 
position of the tumour and/or surrogate during treatment allows for a more 
efficient treatment delivery, as minimising the beam off time is of concern in a 
busy clinical department. Turning the radiation beam on and off during treatment 
necessitates longer treatment times, which has a negative effect on patient 
throughput.6 
 
Furthermore, not all patients are capable of breathing in a reproducible manner 
during one session of 4DCT simulation, and many cannot manage reproducibility 
over the many fractions of radiotherapy treatment.73 Although audio and visual 
respiratory coaching have provided positive results in patient breathing 
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reproducibility,11,75 pre-selecting patients suitable to respiratory gated treatment 
and/or 4DCT simulation would expedite the process and provide confidence in 
delivering a gated treatment.12,40 
 
1.4 CONSIDERATIONS IN PATIENT SELECTION FOR RESPIRATORY GATED 
RADIOTHERAPY 
Reproducibility and regularity of the breathing track are two key factors in 
acquiring a 4DCT scan and accurately delivering respiratory gated radiotherapy. 
The breathing track must be reproducible day to day as well as within each 
fraction,17 particularly if using the 4DCT scan to plan a gated treatment,29 and it 
must also demonstrate a regular pattern to allow confidence in a gated 
treatment.40 Figure 1.3 shows the breathing waveform acquired from the same 
patient over three separate fractions.  
 
The variation in the three waveforms highlight the risk of planning a gated 
treatment based on a single 4DCT scan, without examining the inter-fraction 
variations. Planning a gated treatment delivery based on the first fraction would 
result in significant mis-treatment of the moving tumour in each consequent 
fraction. Furthermore, extended observations are required as shorter tracks may 
fail to record critical characteristics of waveform.17 In fraction 3, the patient’s 
breathing waveform significantly changes characteristics after 2 min. 
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Figure 1.3 Breathing waveforms from the same patient over 3 separate fractions, showing 
distinctly different characteristics in each fraction.  
 
Fraction 1 
Fraction 2 
Fraction 3 
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Without coaching, this patient does not appear to be a suitable candidate for 
respiratory gated radiotherapy due to the risk of mis-treatment. However, 
qualitatively inspecting breathing waveforms does not provide a rigourous 
method for patient selection. A quantifiable method to test a potential patient’s 
ability to breathe reproducibly would better assist in the selection process 
 
1.5 RESPIRATORY MOTION MODELS 
Many researchers have attempted to model the respiratory motion of both an 
external marker and the internal tumour in order to adapt and improve the 
treatment delivery to the patient. There exist several models to predict a patient’s 
breathing waveform;38-39,76-78 however the irregularity of real-time free breathing 
waveforms defeat the predictive capabilities of the models which, whilst capable 
of modeling unusual patterns,38 cannot predict abrupt changes, such as a cough 
or sigh, from the steady state pattern.79  
 
An alternative approach is to analyse a patient’s breathing waveform and 
establish criteria by which to determine the patient’s suitability for respiratory 
gated radiotherapy. Quantifiably characterising the breathing waveform is one 
method that can be used to establish criteria for the decision making process. 
 
Wu et al.38 designed a finite state model for on- and off-line respiratory motion 
analysis, characterising the breathing waveform by segmentation into exhale, 
end of exhale and inhale states and defining parameters such as amplitude, 
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stability of the motion and the breathing period. George et al.76 likewise 
determined the mean position, amplitude and period of each breathing cycle in 
the waveform. 
 
Ruan et al.79 profiled the respiratory induced tumour motion in order to predict the 
semi-periodic movement. Three parameters were identified by Ruan et al: 
baseline drift, frequency variation and fundamental pattern change. Each of 
these parameters were chosen for their usefulness as physiological or clinical 
indicators. 
 
1.6 AIM 
The aim of this research was to quantify and assess the reproducibility of five 
parameters that describe characteristics of the breathing waveform, and to 
determine if one or more of these parameters could be used as selection criteria 
to effectively assist the clinician in the decision to proceed to 4DCT simulation for 
treatment planning and gated treatment.  
 
Once established, the parameters could also provide a means of quantitatively 
assessing the effectiveness of audio visual coaching on the patient’s respiratory 
motion. 
 
Due to the small cohort and short length of breathing tracks acquired for this 
study, as described in the next section, it is not the intention of this research to 
provide a definitive protocol for patient selection to gated radiotherapy, but rather 
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to present the reproducibility of each parameter so that a decision may be made 
by the clinician with consideration of other physical and logistical constraints 
within a radiotherapy centre. 
 
1.7 PARAMETERS FOR PATIENT SELECTION IN RESPIRATORY GATED RADIOTHERAPY 
For this investigation, the RPM and a customised spirometer were used to record 
the breathing waveforms of three healthy volunteers and nine lung cancer 
patients enrolled in an ethics approved study at the Peter MacCallum Cancer 
Centre in Melbourne, Australia. The breathing waveforms were then analysed in 
order to determine suitability for respiratory gated radiotherapy. 
 
Considering the models described in the previous section, which have been 
positively correlated with patients’ breathing waveforms, five parameters were 
established for this study as indicators of a patient’s suitability for respiratory 
gated treatment: cyclic baseline, frequency, amplitude, asymmetry and relative 
duty cycle. 
 
Each parameter is calculated from the breathing waveform and assessed for 
intra- and inter-fraction reproducibility. The resulting quantification of the 
waveform will allow the clinicians and treatment staff to determine which 
parameters are of clinical interest in their centre, considering the variety of 
simulation and gating equipment available.  
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Testing patient eligibility early in the treatment process will minimise time, 
resources and patient discomfort in the event that the patient is unsuitable for 
gated radiotherapy or alternatively, whether intervention in the form of breathing 
coaching would be useful and/or successful. 
 
Quantifying each parameter and its intra- and inter-fraction reproducibility 
manually is time consuming and subject to inter-observer variations. A software 
tool was developed in MatLab (Mathworks, Natick, USA) to render the process 
more efficient and reproducible, and can be easily adapted to accept input from 
any respiratory motion surrogate. The software characterises the free breathing 
waveform by quantifying the five parameters. The software also computes a 
relative potential duty cycle from the patient’s free breathing, providing 
information as to whether the patient is able to sustain a reasonable steady state 
of breathing during which the radiation beam may be turned on, relative to the 
beam off time. 
 
By quantifying the parameters which describe the waveform, it is possible to 
ascertain the patient’s intra-fraction respiratory reproducibility. Acquiring 
breathing waveforms over several fractions will allow inter-fractional 
reproducibility analysis. This software can also be used to gauge any benefit 
achieved by coaching. 
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There is a plethora of research investigating methods and technology for 
respiration motion compensation in radiotherapy, however the literature on the 
selection of patients suitable for gated treatment is less profuse. This research 
will enhance the current body of knowledge by providing a method of patient 
suitability screening to assist in the decision to implement 4DCT and/or 
respiratory gated radiotherapy, and quantify the results of audiovisual coaching. 
 
1.8 THESIS OUTLINE 
This report describes the methodology and equipment used to acquire the 
breathing waveforms from the healthy volunteers and patients in Chapter 2: 
Assessment of Breathing Motion, with descriptions and illustrations of each 
parameter investigated. Chapter 3: Software Development, describes the 
operation of the software, the algorithms used to quantify each parameter and 
the reproducibility. Chapter 4: Results and Chapter 5: Discussion, contains the 
results of the analysis of all the waveforms, separated into spirometry and RPM 
for the volunteers, and RPM only for the patients. The results are considered in a 
clinical context for patient selection to respiratory gated radiotherapy. An analysis 
of the correlation between the two surrogate methods used is also presented. 
Chapter 6: Conclusions, summarises the development of the software and the 
findings from the waveforms analysis, and describes future investigations 
proposed for the software tool. 
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2 ASSESSMENT OF BREATHING MOTION 
For the application of respiratory gated radiotherapy in the clinical environment, 
the tumour position may be indicated with the implantation of fiducial markers 
and monitored using fluoroscopy. For diseases such as lung cancer, there is a 
risk of pneumothrorax associated with the insertion of fiducial markers, hence 
many clinics prefer the use of external surrogate methods to denote the tumour 
displacement with respiratory motion.51-52,80 
 
2.1 SURROGATES FOR BREATHING 
There are many surrogates for breathing motion that are commercially available. 
Devices such as the Anzai pressure sensor, Varian’s Real time Position 
Management system (RPM) and spirometry are all simple to use, varying only in 
cost and clinical requirements.  
 
These methods are non-invasive compared to invasive techniques such as the 
implanted fiducial markers. However, the pressure bellows and reflective marker 
methods can only reflect the exterior displacement motion. A spirometer has the 
advantage over the other two methods in that it measures not only the rate of air 
exchange, but also the volume of air exchange;81 Lu et al. demonstrated that the 
internal volume of air has been highly correlated  with tissue motion.82  
 
Another advantage of the spirometer is that it is not affected by daily variations in 
patient setup; whereas external markers rely on reproducibility of the daily patient 
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setup, from which deviations which may result in errors in tumour position. 
Furthermore lung volume changes, as measured by the spirometer, can be 
directly correlated with tumour position, whereas abdominal or thoracic 
displacements do not always correlate.83 
 
There have been many studies, as reported in Chapter 1: Introduction and 
Literature Review, on the correlation between external surrogates and internal 
tumour motion, with varying results. Hosiak et al.66 investigated this correlation in 
five patients with non small cell lung cancer. They reported that the correlation 
coefficients ranged from 0.99 to 0.39 (p < 0.0001) when comparing the superior-
inferior tumour displacement as imaged with fluoroscopy, against respiratory 
volume measured with spirometry and abdominal displacement as measured 
with a 3D motion tracking system. There was a stronger and more reproducible 
correlation between respiratory volume and internal tumour motion, although only 
1 of the 5 patients in the study displayed day to day consistency between tumour 
motion and either of the 2 surrogates.66 
 
In a later study, Ionascu et al.52 investigated the 3D tumour motion using 
implanted fiducial markers at or near the tumour, visualised using fluoroscopy in 
real time. This was then correlated with the 1D external abdominal motion using 
a laser based reflective system. The results of 10 lung cancer patients treated for 
up to 12 fractions with amplitude based gating were presented, indicating that 
time shift and amplitude mismatch in the anterior-posterior direction was 
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relatively large, up to 0.55 s and 4.7 mm respectively. However, they found good 
correlation along the superior-inferior direction. With time shift and amplitude 
mismatch of 0.2 s and less than 3.0 mm respectively.52 
 
Other studies have found a good correlation between internal tumour motion and 
an external respiratory surrogate. In a six patient study, Mageras et al.67 
positioned the RPM marker on the patients’ diaphragm and examined the 
relationship with internal anatomic motion using fluoroscopy. They found that the 
introduction of audio coaching improved the correlation between the external 
surrogate and internal anatomic motion up to a mean correlation coefficient of 
0.97 (range 0.95 to 0.99) in all but two patients, who had impaired lung 
function.67 
 
However for the purposes of this study, the correlation between tumour motion 
and the surrogate displacement was not a concern; rather, the reproducibility 
both intra- and inter-fraction for each patient was investigated and compared with 
other patients and volunteers. A spirometer and the RPM system were used to 
record the breathing tracks. 
  
2.1.1 Spirometry 
The spirometer is a device commonly used to measure flow and/or volume with 
respect to time. The data acquired as volume over time, known as a spirogram, 
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may be analysed to obtain key pulmonary ventilation features, such as vital 
capacity, dynamic lung volume and total lung capacity.84 
 
The two main types of spirometer are volume displacement and flow.85 When 
used for respiratory gating in radiation therapy, flow spirometers are the more 
commonly used.42,83 A simple flow spirometer for this application incorporates a 
transducer that senses pressure differentials and converts the signal from flow 
into pressure. The signal is then amplified, converted from an analogue to digital 
signal and the resulting spirogram is presented on a computer screen for further 
analysis or manipulation.83 A simple schematic of this process is illustrated in 
Figure 2.1. 
 
 
Figure 2.1 Simple schematic of the spirometry process. 
 
Flow spirometers are extremely portable, provide immediate results and are 
simple to use and maintain,85 although they exhibit a tendency to drift from 
baseline due to the electronics and circuitry involved. They are however, able to 
measure inspiratory volume, a distinct advantage over the volume 
spirometer.83,85 
 
The spirometer used in this study was designed and built in-house, and has a 
sampling rate of 0.054 s. The relationship between the output of the transducer 
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and flow rate was determined using a calibrated 3 l syringe. Air from the syringe 
was expelled into the spirometer at a constant flow rate, for five different rates. 
The zero point was considered the baseline. A constant flow rate was achieved 
by manually depressing the syringe over five different constant time intervals.  
 
Whilst the uncertainty in calibration is unknown for this particular spirometer, 
other studies have found that the two major sources of uncertainty in spirometry 
is the calibration error and the stochastic baseline variation error.83  Studies have 
found calibration error to be less than 1% of 3 l  and therefore negligible, and 
baseline variation error as high as 20% of the normal breathing amplitude, which 
is not insignificant.83 To compensate for this, Zhang et al.83 proposed a method of 
dynamic flow baseline adjustment after every dynamic volume baseline 
adjustment. The spirometer used in the current study was programmed to reset 
the baseline to zero following each exhalation to avoid baseline drift. 
 
The uncertainty in the 3 l  syringe itself is also not known, however Cramer et 
al.86 found that the 6 l  syringe used in their study was correct within 0.36% at 
22oC. The uncertainty in our measurements is likely to be slightly larger due to 
the smaller volumes used. 
 
The flow rate in l /s was plotted against the known pressure difference. The 
relationship between pressure and flow rate is linear, hence the transducer can 
be calibrated using the gradient of the line of best fit, as shown in Figure 2.2. 
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Figure 2.2 Relationship between transducer output and flow rate for the spirometer. 
 
The Ultipor 25 anaesthetic filter with a monitoring port (Pall Corporation, NY, 
USA) was used in conjunction with the spirometry system (Figure 2.3 (a)). This 
type of device features a ceramic bonded, pleated, hydrophobic High Efficiency 
Particulate Absorbing (HEPA) filter in a transparent housing. The HEPA filter 
provided a bidirectional barrier against air- and liquid-borne bacteria, viruses and 
particulate matter, ensuring a safe environment for the volunteers’ repeat 
measurements. The Ulitpor filter has a resistance of approximately 3.6 cm H2O at 
a flow rate of 60 l /min. This was considered acceptable for the spirometry 
measurements.87 
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Figure 2.3 (a) Anaesthetic filter used for spirometry data acquisition attached to transducer and 
(b) schematic of anaesthetic filter.  
 
The volunteers breathed into a coaxial lumen with an outer diameter of 22 mm 
and internal diameter of 15 mm. Differential pressure is created at the HEPA filter 
in the centre of the unit as the other open airway is subject to ambient air 
pressure. The filter’s C02 monitoring port was attached to the temperature 
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compensated transducer, as shown in Figure 2.3 (a) and (b). The transducer is 
designed to operate at a temperature span of 0 to 70oC with a typical uncertainty 
of 0.1% of the span relative to 25oC. The analogue to digital converter used was 
an 8 bit device, giving 256 points over its measuring range.  
 
After a brief training period, volunteers had no difficulties using the system which 
required them to breathe solely through their mouth into the filter. A rubber 
snorkel mouthpiece and firm nose clip (Figure 2.4) was used initially, however all 
volunteers preferred to forgo the mouthpiece and noseclip, finding them 
uncomfortable. The breathing tracks used for analysis were acquired without 
these implements, with no discernible variation in the waveforms. 
 
 
Figure 2.4 Noseclip and rubber mouthpiece. The noseclip proved uncomfortably tight for all 
volunteers and the snorkel piece caused oral discomfort when used over long time periods. 
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2.1.2 Real Time Position Management 
The RPM Respiratory Gating System is comprised of a camera, a light source 
and a small plastic box. It is used to track the vertical motion of a patient’s 
respiration by way of an external surrogate placed on anatomical regions directly 
affected by respiratory motion, such as the chest wall and upper abdomen, at a 
sampling rate of 0.04 s.  
 
The camera is a charged-coupled device tracking camera. It is sensitive to 
infrared light, which is provided by a ring of infrared light sources through which 
the camera lens is fitted (see Figure 2.5).68 An LCD monitor enables the video 
tracking to be viewed within the treatment room.  
 
 
Figure 2.5 RPM camera showing the ring of infrared illuminators; the camera lens may be difficult 
to see in the centre of the ring of lights. 
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A small plastic box acts as an external respiratory motion surrogate. It has two 
reflective markers and was placed on the volunteer’s chest wall. The markers 
reflect the infrared light back to the camera, which in turn sends the video signal 
to the RPM Respiratory Gating System (see Figure 2.6).  
 
 
Figure 2.6 Marker box with 2 reflective markers, positioned here on a motion phantom that 
moves in an elliptical pattern. 
 
The box with 2 markers only allows tracking in the vertical plane, following the 
rise and fall of the volunteers’ chest wall motion as a surrogate for respiratory 
motion. A recent release by Varian incorporates 6 markers on the block, allowing 
3D motion tracking. However, this was not available at the time of data 
collection.68 The software displays the breathing motion as phase-based and 
amplitude-based. 
 
Motion tracking is established when the camera captures the infrared reflection 
from the markers. However, a pair of spectacles or other reflective object in the 
2 reflective markers on small 
plastic box 
Motion phantom 
On/off switch 
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field of view may interfere with the establishment of the tracking. Volunteers were 
asked to remove such objects prior to motion tracking. 
 
The RPM marker box is non-invasive and does not require any other fixation 
equipment. In this regard, RPM is the least invasive of all the commercially 
available surrogates for respiratory motion. 
 
 
Figure 2.7 Position of the reflective marker box on a volunteer. 
 
Although the system has submillimetre accuracy it is subject to inter-fraction 
setup errors. Setup error values of 2 mm up to 4 mm have been cited in the 
literature, with random errors of 3.2 mm and 2.6 mm in the transverse and 
cranio-caudal planes respectively.88-90 For this study, the marker box was placed 
in relation to bony anatomy, typically 5 cm inferior to the xiphoid process (Figure 
2.7). Whilst care was taken to position the marker reproducibly some inter-
fraction setup uncertainty remained, which will be discussed in section 5.3 
Limitations: RPM. 
 
RPM Camera system 
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2.2 DEFINITONS OF PARAMETERS INVESTIGATED 
Reproducibility and regularity of the breathing track are two key factors in 
acquiring a 4DCT scan, for the purpose of planning and delivering respiratory 
gated radiotherapy.12,17,29 The breathing track must be reproducible day to day as 
well as within each fraction, and it must demonstrate a regular pattern to allow 
confidence in a gated treatment. Whilst respiratory correlated cone beam CT 
imaging on the linac at the time of treatment may reduce or eliminate inter-
fraction errors, random intra-fraction variations cannot be eliminated. Determining 
a patient’s ability to maintain a reproducible breathing pattern over a typical 
treatment time of 10 – 15 min69 prior to implementation of respiratory gated 
radiotherapy would assist in selecting patients with a reduced potential for intra-
fraction variation. 
 
For this research, several parameters were established to quantitatively analyse 
the characteristics of breathing tracks acquired with spirometry and RPM. The 
parameters selected for investigated were: Cyclic baseline, amplitude (inhale and 
exhale), breathing frequency, asymmetry and maximum duty cycle (inhale and 
exhale). The first four parameters describe various aspects of a breathing 
pattern; the maximum duty cycle was calculated in order to assess the typical 
time a person is able to spend in one part of the breathing cycle. This determines 
the length of time the radiation beam may be turned on. From a practical 
perspective, a longer duty cycle is desirable as it allows for a longer beam on 
time. This enables the gated treatment to progress more quickly as the radiation 
is not constantly switching on and off.  
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The mathematical expressions used to calculate these parameters will be 
discussed in section 3.3 Calculation of parameters. 
 
2.2.1 Cyclic Baseline 
Published literature refers to a baseline, a reference position which is typically 
determined at the end of exhale due as it is considered the most stable portion of 
the breathing cycle, or the mean tumour position.29,64,91 For this work, the mean 
portion of the breathing cycle was used as a substitute for the mean tumour 
position. However, a model breathing track exhibits inhale and exhale functions 
which rise and fall about a mean point, the baseline, that remains steady 
throughout the entire time period under investigation (Figure 2.8 (a) dashed line). 
The physical reality does not conform to this; the mean point between inhale and 
exhale varies with each breathing cycle, requiring a moving baseline (Figure 2.8 
(b) solid line) to accommodate the fluctuations. As the baseline is calculated for 
each inhale and exhale cycle, it is named the cyclic baseline. 
 
For this investigation, the mean cyclical baseline is calculated by establishing a 
baseline for each breathing cycle and averaging over the time period of interest. 
This parameter is important as it is also used to derive the amplitude and 
asymmetry. 
 
The dashed line in Figure 2.8 (b) shows the mean cyclic baseline. The variation 
in the baseline from cycle to cycle is an important indicator of the flatness of the 
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breathing waveform. Gated treatments using the RPM rely on the reflective 
marker box rising and falling within a window determined at the start of treatment 
for each fraction. Variations in the mean cyclic baseline indicate the waveform is 
deviating, a pre-cursor to the RPM system losing the reflective signal from the 
marker box. This would result in a longer treatment time as the system re-tracks 
the marker, causing undue discomfort for the patient. 
 
(a)    
 
 
(b)  
 
Figure 2.8 (a) Model breathing track with flat baseline shown as a solid line, and (b) RPM patient 
breathing track with moving baseline as a solid line, and average baseline as a dashed line.  
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2.2.2 Amplitude 
In the case of spirometry, the amplitude describes the maximum volume inhaled 
and exhaled with each breath. For RPM, the amplitude reflects the displacement 
of the marker box on the chest wall with respiratory motion. As seen in Figure 2.8 
(a), a model breathing track would result in a fixed value of maximum inhale and 
exhale amplitude for each breath. However, Figure 2.9 shows that this is not the 
case in a physical breathing track. In order to obtain the mean cyclic baseline, 
the maximum points of inhale and exhale were averaged. This resulted in a 
symmetrical amplitude value for inhale and exhale for each breathing cycle, and 
will be discussed in further detail in section 5.1 Evaluation of Parameters: 
Amplitude. 
 
 
Figure 2.9 The inhale and exhale amplitudes are dependent on the moving baseline. 
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2.2.3 Breathing Frequency 
The number of breaths per minute illustrates the respiration rate. An increased 
breathing frequency may be observed in the first few fractions before the patient 
becomes accustomed to the measurement and setup. An increased breathing 
frequency may also be apparent at the beginning of each fraction breathing track 
before the patient settles into the measurement for each fraction. 
 
2.2.4 Asymmetry 
The symmetry of a breathing track is an indication of the regularity of respiration.  
A more irregular breathing track would exhibit amplitudes of varying height and 
different amounts of time spent at a particular phase of the breathing cycle.  
 
 
 
 
Figure 2.10 The inhale and exhale amplitudes are dependent on the moving baseline.  
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The asymmetry parameter may be quantified in many ways; for this investigation, 
the mean asymmetry was calculated using the points in time at which maximum 
inhale and exhale amplitudes were attained. Figure 2.10 illustrates the concept, 
where asymmetry is defined as 
11
1
−+
−
−
−
ii
ii
tt
tt
. This is further described in section 
3.3.6 Asymmetry. 
 
2.2.5 Relative Duty Cycle 
Duty cycle (DC) is of particular interest in respiratory gated radiotherapy. This 
parameter describes the length of time the radiation beam may be switched on 
during the patient’s treatment.  
 
 
 
 
Figure 2.11 Illustration of the points used to calculate the inhale and exhale duty cycles. 
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A longer duty cycle is preferable as it minimises the number times the radiation 
must be switched off to accommodate respiratory movement. There is much 
debate as to whether gated treatment should occur at the inhale or exhale 
portion of the breathing cycle. For this investigation both the inhale (IN) and 
exhale (EX) duty cycles are calculated as the maximum amount of time spent 
within 20% of the maximum inhale amplitude, or 20% of the maximum exhale 
amplitude of the breathing cycle respectively. These values are then divided by 
the frequency of breathing (breaths per minute) to achieve the duty cycle. This is 
illustrated in Figure 2.11 and further described in section 3.3.7 Relative Duty 
cycle. 
 
The term ‘relative duty cycle’ (DCrel) is introduced to distinguish this term from the 
definition of duty cycle as used in published literature, which is the ratio of 
radiation beam on to beam off time. 2,64  
 
2.3 VOLUNTEERS AND PATIENTS 
Three male volunteers of similar age, health and level of fitness were selected. 
The volunteer breathing tracks were acquired for both spirometry and RPM 
simultaneously. Synchronising the Spirometer and RPM to commence recording 
simultaneously proved to be difficult due to the RPM’s initial tracking of the 
marker box; tracking continued until the RPM recorded a stable waveform, at 
which point the breathing track recording commenced. Initiating each device 
separately and stopping them together was a simpler solution. The breathing 
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tracks were therefore synchronised from the end of the file, rather than the 
beginning.  
     
The breathing tracks from nine lung cancer patients who had consented were 
acquired from the ethics approved study "Observation of patient breathing 
patterns using a commercial radiotherapy gating system' at the Peter MacCallum 
Cancer Centre in Melbourne, Australia. No specific requirements for tumor type 
and stage were stipulated in the study but all patients had to be treated with a 
radiotherapy regimen of at least 5 weeks of treatment. Patient data were 
acquired using the RPM system during verification imaging and treatment of the 
patients, with all of them in treatment position. No patients were treated using 
respiratory gated radiotherapy in this study. However, the data from 8 patients 
only were able to be analysed for this study. Some patients had fewer than 3 
breathing tracks recorded, or the tracks were terminated prematurely. Only 
patients with 3 or more breathing tracks of 2 min or longer were analysed for this 
study. 
 
2.4 DATA ANALYSIS 
The spirometry and RPM data were analysed for both intra- and inter-fraction 
variability. The algorithms used for analysis are described in section 3.3 
Calculation of parameters.  
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2.4.1 Volunteers 
For each volunteer, spirometry and RPM breathing tracks were acquired 
concurrently. 1 min breathing tracks were acquired over three separate fractions, 
and a 5 min breathing track was acquired on the final day.  
 
A 15 min acquisition was planned for both the spirometer and RPM on the final 
day, similar to a typical treatment timeframe. However failure to adjust the 
acquisition setting on the RPM for all volunteers resulted in only the final 5 min of 
RPM data being recorded. Due to logistical difficulties, repeated measurements 
with the correct settings were not possible. For direct comparison purposes, only 
the final 5 min data for the spirometer are presented along with the RPM data. 
 
For each volunteer, intra-fraction analysis was performed on the 1 min and 5 min 
breathing tracks. Inter-fraction analysis was performed by combining all of the 
data from each of the 1 min breathing tracks and analysing as a whole. The inter-
fraction results were compared to the longer 5 min breathing tracks in order to 
establish the variation, if any, between a short and longer data acquisition time 
frame. von Siebenthal et al. caution against the use of short time frames to 
determine reproducibility of motion.32 
 
2.4.2 Patients 
Patient breathing track lengths varied from 0.75 min up to 5 min, over three to 
seven fractions. Not all patient breathing tracks could be analysed due to 
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extreme irregularities or insufficient time (Figure 2.12). Of the 50 patient 
breathing tracks acquired, 38 (76%) were able to be analysed.  
 
For each patient, intra-fraction analysis was performed on the 2 min breathing 
tracks. Inter-fraction analysis was performed by combining all of the data from 
each of the 2 min breathing tracks and analysing as a whole. Only patients with a 
minimum of three breathing tracks of 2 min or longer were included in the study 
in order to allow meaningful inter-fraction comparisons to be made. 
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Figure 2.12 Highly irregular and insufficient breathing tracks acquired from three different 
patients on the RPM. 
 
The irregularities in the patient breathing waveforms or lack of breathing tracks 
may be attributed to several patient or staff factors, such as an unusually large 
motion during acquisition for the former, and accidentally over-writing a previous 
recorded track by the latter. Other reflective objects in the near vicinity of the 
RPM reflective marker box, such as a pair of glasses worn by the patient, may 
also cause the RPM tracking to fail. 
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2.4.3 Reproducibility and Behaviour 
All results are presented as the mean ± standard deviation (SD), where the SD is 
an indication of the variability of each parameter for each volunteer and patient. 
For the volunteers, the parameters calculated from the 5 min breathing tracks are 
also presented as a running mean and SD over the time period in order to 
visualise the intra-fraction variation of each parameter with time, except in the 
case of the duty cycle. The running mean and SD were not calculated for the 
relative inhale and exhale duty cycles due to the difficulty in establishing a 
temporal location for each period of inhale or exhale in the software.  
 
The volunteers’ RPM and spirometry results were further analysed to determine 
the correlation between the two surrogate methods. A high degree of correlation 
would indicate that the parameters presented in this study are suitable to assist 
in the decision making process when considering patient suitability for respiratory 
gated radiotherapy, irrespective of the respiratory surrogate employed. This is 
particularly beneficial for those departments which have already invested in one 
system. 
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3 SOFTWARE DEVELOPMENT 
Software was developed in Matlab (Mathworks, Natick, USA) to analyse the 
breathing tracks obtained with the customized spirometer and RPM. This was 
achieved using two streams of code which incorporate the algorithms for each 
parameter and output the results into a spreadsheet.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Flow diagram of software operation. 
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The software calculates the cyclic baseline, amplitude, breathing frequency per 
minute, asymmetry and relative duty cycle (inhale and exhale) from each 
breathing track for a given time period. There are 4 major components to the 
software, as shown in Figure 3.1.  
 
3.1 INPUT 
Data input was via the Matlab command window, as a user interface was not 
developed for this study. The file format is specified as either spirometry or RPM. 
Figure 3.2 (a) and (b) shows the different formats of the spirometry and RPM text 
files respectively.  
 
             
(a)            (b) 
Figure 3.2 Example of (a) spirometry raw data and (b) RPM raw data. 
 
The user is able to specify the time period of interest in digital format, as well as 
the sampling rate of the device for spirometry only, as this varies between 
different vendors. The level of data filtration is also specified in order to disregard 
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artifacts such as a cough or staggered breathing, which affect the detection of 
the maximum and minimum points, Peaks and Troughs respectively. This is 
further explained in the next section. 
 
3.2 DATA PROCESSING 
3.2.1 Spirometry Data 
The subroutines that process the 2 types of input are identical save for the 
additional processing required of the spirometry data.  The spirometry raw data is 
recorded as pressure. As explained in section 2.1.1 Spirometry, this can be 
considered the flow rate in litres/sec. In order to convert the raw data into volume 
the integral of flow rate, which is volume V, over time t, was required: 
 
∫
t
dt
dt
dV
0
 
 
 
A zero offset for ambient pressure, κ, was programmed as a user definable input. 
This is a value calculated by the spirometry operating software, with an option for 
the user to enter a value. Prior to recording a breathing waveform, the spirometer 
establishes a system baseline with no external influence. The volunteer is then 
instructed to place the anaesthetic filter in position and commence breathing 
normally. The software analyses the values between 1 and 2 s at the start of the 
entire breathing track (ie not only the time period of interest) and suggests a 
value for κ based on the statistical mode. Slight changes in κ result in significant 
changes in the baseline, as demonstrated in Figure 3.3.  
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Figure 3.3 Changes in the baseline with change in the ambient pressure offset, κ: (a) κ = 98, (b) 
κ = 99 and (c) κ = 100. 
(a) 
(b) 
(c) 
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Note how the baseline shows an increasing or decreasing drift with an incorrect 
value of κ (Figure 3.3 (a) and (c)). In this case, the software suggested a value of 
κ = 99 (Figure 3.3 (b)). 
 
3.2.2 Peak Detection 
The determination of the points of peaks and troughs are essential for the 
calculation of all parameters. To avoid the inclusion of noise or false peaks due 
to coughs or other non-respiratory displacements in the calculation of the 
parameters, a subroutine was used to allow the user to select the level of 
filtration required. 
 
The zero-derivative method was not suitable for peak detection as the zero 
crossing of the first derivative could return a false peak; it is more difficult to set a 
threshold to filter out false peaks. Instead a peak detection function, written in 
Matlab by Bilauer,92 was included in the software. The function identifies a peak 
as the highest point between 2 valleys, ie it is surrounded by lower points.92 
Including this function in the software allowed the user to define the minimum 
separation between a high point and the surrounding points, thereby eliminating 
the false peaks.  
 
Charting the breathing track during software execution enabled the user to 
visualise the level of filtration applied and/or required. Figure 3.4 shows a cutout 
segment of RPM data as charted by the software. The white circles indicate the 
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peaks, or maximum inhale, and the black points indicate the troughs, or 
maximum exhale. A false peak is evident during the first inhale phase. Defining a 
minimum level of separation or threshold (Th), yTh, between the highest point and 
the surrounding points excluded this false peak from analysis.  
 
 
 
Figure 3.4 Example of peak detection level set to exclude a false peak using a cut-out section of 
an RPM waveform, where the x axis is time and the y axis is displacement. 
 
3.3 CALCULATION OF PARAMETERS 
Each parameter is calculated as a mean value, except in the case of relative duty 
cycle, where the maximum value is reported.  
 
 
y 
y  <  yTH,  
∴ no peak detected 
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3.3.1 Standard deviation and standard error of the mean 
For all parameters, the standard deviation, SD, and standard error of the mean, 
SEM, at a 95% confidence interval is calculated, where Zσ  is the standard 
deviation of the parameter, z,  iz  is the value of the parameter at each breathing 
cycle and x  is the mean value of the parameter for the time period of interest: 
 
( ) 21
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1
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−
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where n is the number of breathing cycles.  
 
3.3.2 Peaks and troughs 
The software engages one of two approaches, depending on whether the first 
entire phase in the time period of interest is an inhale (Peak) or an exhale 
(Trough). Figure 3.5 (a) and (b) illustrates the breathing track over a time period 
of interest, where the first full phase is inhale and exhale respectively.  
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           (a)            (b) 
 
Figure 3.5 (a) Initial complete phase is inhale, and (b) initial complete phase is exhale. 
 
The following definitions assume an initial inhale phase; the definitions for an 
initial exhale phase do not differ greatly save for a reversal of the P and T values 
where required. 
 
3.3.3 Cyclic Baseline 
The mean cyclical baseline is calculated by establishing a baseline for each 
breathing cycle and averaging over the time period of interest. This is the most 
important parameter calculated, as the amplitude and asymmetry are derived 
from the cyclical baseline. The method of calculation developed here is unique 
compared to the more common method of using a global baseline. For short time 
periods that incorporate only a few breathing cycles, there is no significant 
difference in the two methods. However, for the longer breathing tracks as 
acquired for this study, the differences become considerable. This will be 
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described in further detail in section 5.1 Evaluation of Parameters: Cyclic 
Baseline.  
 
The mean cyclic baseline, B , is calculated as follows: 
 
∑ +=
=
N
j jj
cycles
TP
n
B
12
1
 
 
where ncycles is the number of breathing cycles between t0 and tN, and  Pj and Tj 
indicate the peak and troughs which lie between t0 and tN. 
 
3.3.4 Amplitude 
The mean amplitudes of inhale and exhale are first re-centered to the mean 
cyclic baseline, thence calculated as:  
 ( )
2
' jj
tt
TP
AA
ii
+
−=  
where itA'  is the re-centered amplitude. Pj and Tj indicate the peak and troughs 
which lie between t0 and tN. 
 
This method of calculation results in equal values of inhale and exhale amplitude, 
or in the case of spirometry, volume, about the cyclic baseline. This is further 
discussed in 5.1 Evaluation of Parameters: Amplitude. 
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3.3.5 Frequency 
The frequency of breathing, F, in breathing cycles per minute is expressed as: 
 
s
tt
n
F
N
cycles
 60
0
×
−
=  
where ncycles is the number of breathing cycles in the time period of interest. 
 
3.3.6 Asymmetry 
The mean asymmetry, Λ , is defined as a ratio of the times of the peaks and 
troughs of each successive cycle: 
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3.3.7 Relative Duty cycle 
The time spent within 20% of the maximum inhale, t20% IN, or exhale amplitude 
during each breathing cycle is first calculated. The software calculates the time 
for each inhale and exhale for every breathing cycle and returns the maximum 
time, max%20 INt , found as follows: 
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There is an equivalent metric for the maximum time spent at 20% of the 
maximum exhale amplitude. 
 
The relative duty cycle, DCrel, is calculated by dividing max%20 INt  by the frequency of 
breathing (breathing cycles/min): 
 
%100
 60
max
%20 ×
×
=
s
Ft
DC INrel  
 
The uncertainty in DCrel must therefore be recalculated as follows: 
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where ∆DCrel, ∆ max%20 INt  and ∆F are the uncertainties in the relative duty cycle, the 
maximum time spent at 20% of the maximum inhale amplitude, and the 
frequency of breathing respectively. 
 
3.3.8 Running mean and standard deviation 
This calculation could only be performed where there were sufficient data points 
in the time interval. The follow algorithms were used, where jtn  is the number of 
data points in the time interval ( )1, +ii tt : 
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The relative duty cycle was not calculated directly but as a function of the number 
of breaths per minute. This resulted in varying numbers of data points (for the 
calculated duty cycle compared with the calculated breathing frequency), hence 
the running mean could not be calculated for the relative duty cycle. 
 
3.3.9 Correlation between Real Time Position Management and Spirometry 
A direct correlation of the raw RPM and spirometry data was not possible due to 
the different sampling rates of both systems. As mentioned in sections 2.1.1 
Spirometry and 2.1.2 Real Time Position Management, the RPM and 
spirometer have sampling rates of 0.04 and 0.054 s respectively. The spirometry 
raw data was therefore interpolated to create the same number of data points 
over a given period at the same points in time for both methods. This is illustrated 
in Figure 3.6. 
 
A time offset, determined in MatLab, was also applied as the RPM consistently 
led the spirometry change. The resulting data was normalized to the maximum 
value to allow ease of visualisation. 
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Figure 3.6 Stylised illustration of the different sampling rates for RPM and spirometry. 
 
3.4 OUTPUT 
Figure 3.7 shows the software in its current form. The results are printed to the 
Matlab Workspace window, as well as to an Excel spreadsheet. The software 
also features a simultaneous charting feature to allow viewing of the breathing 
track over the time period of interest. The output for each parameter, and the 
standard deviation, is given. 
 
Time offset 
Interpolate spirometry data 
to create same number of 
points as RPM at the same 
point in time 
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Figure 3.7 Image of the software results in the Matlab Workspace. The charting feature and 
Command window are also shown. 
 
3.5 VALIDATION OF THE SOFTWARE 
The software was tested prior to use in order to ensure its accuracy and validity.  
The following 3 aspects were tested: reproducibility of results, correct time 
intervals and comparison with manually calculated values. 
 
3.5.1 Reproducibility of results 
The software is based on deterministic processes, rather than stochastic, hence 
the results were expected to be reproducible. This was tested by inputting the 
same breathing track with the same variables numerous times. As predicted, the 
software returned exactly the same values for each parameter on each iteration. 
Several breathing tracks were used, each achieving the same result. 
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3.5.2 Correct time intervals 
The software allows the user to specify the time interval required and the 
sampling rate of the device. This was assessed both numerically and graphically 
by inputting a breathing track with a specific time interval and sampling rate. The 
graphical result was accurate as observed in the generated chart, and the 
numerical accuracy was verified by comparison with manually calculated values. 
 
3.5.3 Comparison with manually calculated values 
Spirometry and RPM breathing tracks from a selection of volunteers were 
imported into an Excel spreadsheet, and each parameter manually calculated for 
a specific time period. The manually calculated values were compared with those 
derived by the software. All calculated parameters matched the software values 
to better than 3%; this is due to the slight variation in the manual determination of 
the points of peaks and troughs. 
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4 RESULTS 
Several parameters were established to quantify the characteristics of each 
breathing track, as acquired from the volunteers with both spirometry and RPM, 
and the patients with RPM only.  
 
The intra-fraction mean and standard deviation was calculated for each 
parameter at each fraction. An inter-fraction mean and standard deviation (SD) 
was also calculated across all fractions for each parameter. The SD, a measure 
of the variation in each parameter, is represented by the y-axis error bars. 
 
4.1 EVALUATION OF PARAMETERS 
4.1.1 Cyclic Baseline 
The cyclic baseline was calculated as the mean position of each breathing cycle 
from inhale to exhale, or vice versa. This cyclical baseline was then averaged 
over the time period of interest, yielding the mean cyclical baseline with units in 
ml and cm for spirometry and RPM respectively.  
 
Both the spirometry and RPM systems establish an initial system baseline, a 
relative zero point for the system. This should not be confused with the cyclic 
baseline determined here, which dynamically adjusts for several factors including 
equipment drift and changes in the patient’s breathing. It is difficult to define an 
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absolute value for the mean cyclic baseline without a fixed external reference, 
which was not considered at the time of data acquisition.  
 
For the purposes of this study the variation in the mean cyclic baseline, which is 
an indication of the intra- and inter-fraction reproducibility, is the parameter of 
interest, rather than the absolute value of baseline. 
 
4.1.2 Amplitude 
The points of maximum inhale and exhale were determined for each breathing 
cycle and averaged over the time period of interest. The method of calculating 
the maximum amplitude in each breathing cycle, described in section 3.3.4 
Amplitude, results in equal values for both relative to the cyclic baseline; hence 
only the inhale amplitude results are presented. The units are in ml and cm for 
spirometry and RPM respectively 
 
4.1.3 Frequency 
The number of breaths within the time period of interest was renormalized to 
produce the number of breaths per minute.   
 
4.1.4 Asymmetry 
The time at the moment of maximum inhale and exhale of one breathing cycle, 
followed by the time of inhale of the following breathing cycle, were determined 
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and the degree of asymmetry of each breathing cycle calculated. These 
dimensionless values were then averaged over the time period of interest to 
obtain the mean asymmetry. 
 
4.1.5 Relative Duty Cycle 
The time spent within 20% of the maximum inhale or exhale amplitudes for each 
breathing cycle was averaged over the time period of interest, then divided by the 
frequency of breathing to obtain the inhale and exhale duty cycle respectively. 
This quantity is referred to as the relative duty cycle to distinguish it from that 
defined in published literature as the ratio of radiation beam on to beam off time.  
 
4.2 INTRA- AND INTER-FRACTION VARIATIONS 
The results are categorized by acquisition method thence sub-categorised by 
parameter, grouped into Volunteers and Patients. The intra-fraction results will be 
presented for each subject along with the inter-fraction results. 
 
The inter-fraction results were calculated by combining the data from all fractions. 
For the volunteers, a running mean and standard deviation was also calculated 
for the 5 min fraction (fraction 4) to demonstrate behaviour over time for the 
cyclic baseline, inhale amplitude, frequency and asymmetry.  
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The results for the 5 min fraction are presented next to the three 1 min fractions 
to illustrate variations in each parameter as a function of the longer breathing 
track acquired.  
 
4.3 CONSIDERATION OF THE PARAMETERS: SPIROMETERY FOR VOLUNTEERS 
4.3.1 Spirometry: Mean Cyclic Baseline 
Figure 4.1 shows the mean of the cyclic baseline over each fraction, for each 
volunteer. The volunteers are able to maintain a reproducible intra-fraction cyclic 
baseline given the small standard deviations (y-error bars) for all fractions, 
although volunteers 1 and 2 show larger intra-fraction variation in fraction 4, the 5 
min fraction. This is expected given the longer time of data acquisition. 
 
For volunteers 2 and 3, fraction 4 values are much lower than fractions 1 to 3. 
This variation has an effect on the large inter-fraction variation for those 
volunteers, whereas the inter-fraction variation is not as large for volunteer 1.  
The lower values of baseline during fraction 4 for volunteers 2 and 3 may indicate 
the volunteer relaxing with familiarity. The volunteers had time to become familiar 
with the procedure from fraction 1 through to fraction 4. 
 
Also, as discussed in section 2.4.1 Volunteers, 15 min breathing tracks were 
acquired, of which only the last 5 min were used in direct comparison with the 
RPM acquired tracks. However a larger cohort with longer breathing tracks, and 
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an external reference for absolute baseline values, would be required to verify 
this hypothesis. 
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Figure 4.1 Intra- and inter-fraction spirometry mean cyclic baselines for each volunteer. Fractions 
1 to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
 
The running mean and SD in Figure 4.2 illustrates that the cyclic baseline does 
fluctuate with time over the 5 min fraction, with volunteer 2 showing the most 
variation. This is consistent with the larger intra-fraction variation seen in Figure 
4.1. The larger variation in the 5 min fraction can also been seen for volunteer 1. 
Large or sudden variations in the mean cyclic baseline indicate erratic breathing, 
which can result in the radiation beam switching off or requiring re-tracking. This 
is not desired in gated treatment, where lengthy treatment times due to frequent 
bream-off increases patient discomfort and delays subsequent patients. 
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Figure 4.2 Running mean and SD for spirometry mean cyclic baseline over the 5 min fraction. 
 
In the case of spirometry, changes in the mean cyclic baseline infer a volumetric 
change in the patient’s breathing. Large variations in the mean cyclic baseline 
may be an indicator of patient distress, requiring immediate medical attention.79  
 
All volunteers show good intra-fraction reproducibility in the mean cyclic baseline, 
however the large inter-fraction variations indicate the potential risk of a 
geographical miss when planning a treatment regimen based on an initial 4DCT 
scan; ie the first fraction cannot be used as a predictor of behaviour for 
subsequent fractions. The use of IGRT would be essential in this case. 
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4.3.2 Spirometry: Mean Inhale Amplitude 
For spirometry the amplitude refers to the maximum volume (ml) of air inspired or 
exhaled in each breathing cycle. From Figure 4.3 it can be seen that the variation 
in mean amplitude for volunteer 3 is large, particularly in fractions 2 and 4. 
Volunteer 1 appears more stable with a smaller inter-fraction variation.  
The running mean and SD for fraction 4 in Figure 4.4 shows that volunteers 1 
and 2 are relatively stable over time, whereas volunteer 3 shows large variations. 
This is consistent with the larger SD in Figure 4.3.  
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Figure 4.3 Intra- and inter-fraction spirometry mean inhale amplitudes for each volunteer. 
Fractions 1 to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
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Volunteer 3 may not be a suitable candidate for amplitude-based gated treatment 
due to the large intra-fraction variations observed in Figure 4.4, as well as large 
inter-fraction variation in Figure 4.3. Volunteers 1 and 2 may be suitable, 
however each centre implementing a gated treatment program must define the 
level of acceptability in amplitude variation and accept, or coach, suitable 
patients accordingly. 
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Figure 4.4 Running mean and SD for spirometry mean inhale amplitude over the 5 min fraction. 
 
Large or sudden variations in amplitude delay the treatment time due to constant 
beam-off or re-tracking of the signal, neither of which is desirable for a gated 
treatment due to patient discomfort and decreased patient throughput.  
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4.3.3 Spirometry: Frequency 
Figure 4.5 shows that volunteer 3 is capable of stable, reproducible breathing 
frequency with very little intra-fraction variation. Volunteer 1 shows a downward 
trend in frequency with each successive fraction, suggesting relaxation over time 
with procedural familiarity. However the intra- and inter-fraction variations are 
large, indicating that the first fraction should not be used to predict the behaviour 
of subsequent fractions for volunteers 1 and 2. 
 
 
0
5
10
15
20
25
1 2 3 4 INTERfx
Fraction
Fr
e
qu
e
n
cy
 
pe
r 
m
in
u
te
V1
V2
V3
 
Figure 4.5 Intra- and inter-fraction spirometry frequency for each volunteer. Fractions 1 to 3 are 1 
min acquisitions, fraction 4 is a 5 min acquisition. 
 
Figure 4.6 shows large fluctuations in the mean frequency during fraction 4 for 
both volunteers 1 and 2. This indicates that the first 50 s of these volunteers are 
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not predictive of the behaviour of frequency within the fraction. Volunteer 3 
shows very little variation over time save for a spike in the running SD close to 
100 s. 
 
Highly frequent breathing will correspondingly trigger the beam-off and -on 
function more frequently, irrespective of amplitude- or phase-based gating 
approaches. This will result in a smaller amount of radiation being delivered each 
time the beam is triggered on, which in turn may cause inaccurate dose delivery 
as the radiation output may not be linear in the smaller range.  
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Figure 4.6 Running mean and SD for spirometry frequency over the 5 min fraction. 
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The results from volunteers 1 and 2 imply that they may not be suitable 
candidates for amplitude or phase based gating, as the radiation beam would be 
triggered on and off erratically. Volunteer 3 may be suited to either amplitude- or 
phase-based gating due to the inter- and intra-fraction reproducibility. 
 
4.3.4 Spirometry: Asymmetry 
The method of calculating asymmetry results in an asymmetry value of 0.50 for a 
perfectly regular breathing pattern; hence unlike the other parameters, the 
absolute value of asymmetry is also of interest.  
 
Figure 4.7 shows that the intra- and inter-fraction variations in asymmetry are 
large for all volunteers, particularly for volunteers 1 and 2. 
 
Volunteers 2 and 3 show good symmetry in the waveform pattern, with values 
very close to 0.5 for all fractions. Volunteer 1 shows the most asymmetry in 
fraction 4, illustrated in greater detail in Figure 4.8. Volunteers 1 and 2 show very 
large variation in the running SD during fraction 4. 
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Figure 4.7 Intra- and inter-fraction spirometry asymmetry for each volunteer. Fractions 1 to 3 are 
1 min acquisitions, fraction 4 is a 5 min acquisition. 
 
Large asymmetry in the breathing waveform is an indicator that the patient may 
not be suitable for phase-based gating due to the irregularities from one 
breathing cycle to the next.  
 
Volunteer 1 may not be a good candidate for phase-based gating. Volunteers 2 
and 3 show good absolute asymmetry, however the intra- and inter-fraction 
reproducibility is large for all volunteers. This would result in the radiation beam 
turning on and off erratically in a phased-based gating regimen. Furthermore, the 
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results from the first fraction cannot be used to predict the behaviour of 
subsequent fractions.  
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Figure 4.8 Running mean and SD for spirometry asymmetry over the 5 min fraction. 
 
4.3.5 Spirometry: Relative Inhale Duty Cycle  
The relative inhale duty cycle was not intended as a criterion for patient selection; 
rather it is an indication of how long a patient would typically be able to spend in 
one phase of breathing.   
 
As such, the intra- and inter-fraction variations were calculated by combining the 
standard deviations of the frequency and absolute inhale duty times, as 
explained in section 3.3.7 Relative Relative Duty cycle.  
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The running mean and SD were not calculated for the relative inhale and exhale 
duty cycles due to the difficulty in establishing a temporal location for each period 
of inhale or exhale in the software.  
 
It can be seen in Figure 4.9 that the values of the relative inhale duty cycle may 
be considered stable considering the large intra- and inter-fractional variations for 
all volunteers. 
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Figure 4.9 Intra- and inter-fraction spirometry relative inhale duty cycle for each volunteer. 
Fractions 1 to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
 
The relative inhale duty cycle, as determined in this study, should not be used in 
selecting patients for gated radiotherapy in a clinical setting. Instead, this 
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parameter should be used with caution in estimating the potential beam on time 
relative to the beam off time.  
 
4.3.6 Spirometry: Relative Exhale Duty Cycle 
As with the relative inhale duty cycle, the relative exhale duty cycle was not 
intended as a criterion for patient selection, but as an indication of how long a 
patient is typically able to spend in one phase of breathing relative to the 
frequency of breathing. 
 
As seen in Figure 4.10, the large intra- and inter-fraction error bars indicate that 
all variations are insignificant. 
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Figure 4.10 Intra- and inter-fraction spirometry relative exhale duty cycle for each volunteer. 
Fractions 1 to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
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Similar to the relative inhale duty cycle, the relative exhale duty cycle, as 
determined in this study, should not be used in selecting patients for gated 
radiotherapy in a clinical setting. Instead, this parameter should be used with 
caution in estimating the potential beam on time relative to the beam off time.  
 
4.4 CONSIDERATION OF THE PARAMETERS: RPM FOR VOLUNTEERS 
4.4.1 RPM: Mean Cyclic Baseline  
There is very little intra-fraction variation for all volunteers, as seen in Figure 
4.11, however the inter-fraction variation is very large for volunteers 1 and 3. As 
there was no fixed external reference used from fraction to fraction, the absolute 
value of the mean cyclic baseline is not meaningful in this study. 
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Figure 4.11 Intra- and inter-fraction RPM mean cyclic baselines for each volunteer. Fractions 1 to 
3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
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Figure 4.12 shows that the running mean and SD for volunteers 1 and 3 do not 
exhibit large variation, whereas volunteer 2 shows some fluctuations within the 
first 50 s before stabilising over time. 
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Figure 4.12 Running mean and SD for RPM mean cyclic baseline over the 5 min. 
 
The RPM mean cyclic baseline behaviour for all volunteers is similar to the 
spirometry results (see Figure 4.1), with good intra-fraction reproducibility in the 
mean cyclic baseline. However, the large inter-fraction variations indicate that the 
first fraction should not be used as a predictor of behaviour for subsequent 
fractions. 
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4.4.2 RPM: Mean Inhale Amplitude  
Figure 4.13 shows very little intra- and inter-fraction variation for volunteer 2 
except in fraction 4. Volunteer 1 exhibits larger intra-fraction variation in fraction 3 
as well as larger inter-fraction variation. Volunteer 3 fluctuates from fraction to 
fraction, with large inter-fraction variation. The large inter-fraction variations could 
be the result of small inconsistencies in the placement of the RPM marker. 
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Figure 4.13 Intra- and inter-fraction RPM mean inhale amplitude for each volunteer. Fractions 1 
to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
 
Figure 4.14 shows that the running mean and SD are relatively stable over the 5 
min of fraction 4 for volunteers 1 and 3. For volunteer 2 there is some fluctuation 
within the first 100 s, followed by a more stable pattern for the remaining time. 
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Given the negligible intra-fraction variation in fractions 1 to 3 for volunteer 2, the 
fluctuation within the first 100 s in fraction 4 may be considered an anomaly.   
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Figure 4.14 Running mean and SD for RPM inhale amplitude over the 5 min fraction. 
 
The RPM mean inhale amplitude results do not correspond with the spirometry 
results, where volunteers 1 and 2 were found to have reproducible amplitude and 
volunteer 3 was considered less suitable for amplitude-based gating. In the RPM 
case volunteer 3 clearly shows potential as a candidate for amplitude-based 
gating, as does volunteer 1.  
 
Volunteer 2 may also be suitable, given the consistency after the anomaly. The 
raw breathing waveform exhibits a step-like change at this time, indicating a once 
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off change in the detection system. This highlights the importance of acquiring 
longer breathing tracks when using RPM as a surrogate for respiratory motion. 
 
4.4.3 RPM: Frequency 
From Figure 4.15, volunteer 3 shows very little intra-fraction variation in fractions 
3 and 4, however the large intra-fraction variation in fractions 1 and 2 contribute 
to the large inter-fraction variation. Volunteer 1 shows the largest intra-fraction 
variation in fraction 4, and the largest inter-fraction variation. Volunteer 2 
consistently shows large intra-fraction variation in all fractions, and also has large 
inter-fraction variation. 
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Figure 4.15 Intra- and inter-fraction RPM breathing frequency for each volunteer. Fractions 1 to 3 
are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
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Figure 4.16 shows large fluctuations in the mean and SD frequency throughout 
the 5 min of fraction 4 for both volunteers 1 and 2. Volunteer 3 remains stable in 
mean and SD. This corresponds with the spirometry results, where volunteer 3 
shows good reproducibility during the longer acquisition time of fraction 4, and 
volunteers 1 and 2 show greater fluctuations.  
 
Considering the intra-fraction variability, volunteers 1 and 2 may be less suitable 
candidates for amplitude based gating as the radiation beam would be triggered 
on and off more erratically. Volunteer 3 may be suited to either amplitude- or 
phase-based gating. 
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Figure 4.16 Running mean and SD for RPM frequency of breathing over the 5 min fraction. 
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4.4.4 RPM: Asymmetry 
As with spirometry this method of calculating asymmetry results in an asymmetry 
value of 0.50 for a perfectly regular breathing pattern. Unlike the other 
parameters, the absolute value of asymmetry is also of interest.  
 
The intra- and inter-fraction variation in asymmetry is large for all volunteers 
across all fractions, shown in Figure 4.17. Volunteer 1 shows the largest intra-
fraction, whereas volunteer 2 shows the smallest intra-fraction variation. 
Volunteer 1 also shows the largest inter-fraction variation. 
 
0.0
0.1
0.2
0.3
0.4
0.5
0.6
1 2 3 4 INTERfx
Fraction
M
e
a
n
 
As
ym
m
e
try
V1
V2
V3
 
Figure 4.17 Intra- and inter-fraction RPM asymmetry for each volunteer. Fractions 1 to 3 are 1 
min acquisitions, fraction 4 is a 5 min acquisition. 
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Figure 4.18 shows large variations in the running mean and SD for all volunteers 
across fraction 4, particularly for volunteer 1 at 150 s.  This dramatic fluctuation is 
not present in the spirometry results. 
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Figure 4.18 Running mean and SD for RPM asymmetry over the 5 min fraction. 
 
Similar to spirometry, volunteer 1 may be less suitable for phase-based gating as 
the radiation would be triggered on and off erratically. Volunteers 2 and 3 show 
good absolute asymmetry, however the intra- and inter-fraction reproducibility is 
large for all volunteers, indicating that they are less suitable for phase-based 
gating. 
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4.4.5 RPM: Relative Inhale Duty Cycle 
As mentioned in the earlier section Spirometry: Relative Inhale Duty Cycle, the 
relative inhale duty cycle was not intended as a criterion for patient selection, but 
as an indicator of the length of time a patient is typically be able to spend in one 
phase of breathing.  
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Figure 4.19 Intra- and inter-fraction RPM relative inhale duty cycle for each volunteer. Fractions 1 
to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
 
The uncertainties for this parameter were calculated by combining the standard 
deviations of the frequency and absolute inhale duty times, as discussed in 
section 3.3.7 Relative Duty cycle.  
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From Figure 4.19, it can be seen that the values for the mean inhale duty cycle 
generally fall between 30% and 15%. However the large intra- and inter-fraction 
error bars for all volunteers render any variations insignificant.  
 
4.4.6 RPM: Relative Exhale Duty Cycle 
Similar to the mean inhale duty cycle, the variations in the mean exhale duty 
cycle observed in Figure 4.20 are insignificant for all volunteer, across all 
fractions. However the values generally fall between 18% and 10%. 
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Figure 4.20 Intra- and inter-fraction RPM relative exhale duty cycle for each volunteer. Fractions 
1 to 3 are 1 min acquisitions, fraction 4 is a 5 min acquisition. 
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Typical values of duty cycle reported in the literature range from 30% to 50%.11 
As mentioned several times in this chapter the relative inhale and exhale duty 
cycles may only be used as an estimate of the potential true duty cycle. 
However, the very large error bars indicate that this parameter is not a sensitive 
indicator of duty cycle. 
 
In both spirometry and RPM the standard deviations were consistently larger 
during inhale than exhale, indicating that exhale is the more reproducible phase. 
This is consistent with a study conducted by Vedam et al.64 
 
4.5 CONSIDERATION OF THE PARAMETERS: REAL TIME POSITION MANAGEMENT FOR 
PATIENTS 
As mentioned previously the patient breathing tracks were acquired using RPM 
alone. Of the 9 patients and 50 breathing tracks acquired, only 8 patients and 38 
breathing tracks were able to be analysed due to extreme irregularities in the 
breathing waveform, or insufficient time. Only breathing tracks of 2 min or longer 
were analysed, as discussed in section 2.4.2 Patients. 
 
4.5.1 RPM: Mean Cyclic Baseline 
The mean cyclical baselines for all patients are shown in Figure 4.21. All patients 
show very small intra-fraction variation across all fractions, and large inter-
fraction variation except in the case of patients 3 and 4 who demonstrate the 
smallest inter-fraction variation. 
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Figure 4.21 Intra- and inter-fraction RPM mean cyclic baselines for each patient. 
 
As mentioned earlier in section 4.1.1 Cyclic Baseline, for the purposes of this 
study the variation in the mean cyclic baseline, which is an indication of the intra- 
and inter-fraction reproducibility, is the parameter of interest, rather than the 
absolute value of baseline. 
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Large or sudden variations in the mean cyclic baseline indicate erratic breathing, 
which can result in the radiation beam switching off or requiring re-tracking. 
Similar to the RPM results for the volunteers, none of the patients exhibit this 
behaviour within each fraction.  
 
4.5.2 RPM: Mean Inhale Amplitude 
From Figure 4.22, it can be seen that the inter-fraction variation in the mean 
inhale amplitude is large for all patients, with the exception of patient 3. Patient 4 
in particular exhibits large intra- and inter-fraction variation. 
 
The patients demonstrate less reproducibility than the volunteers in the RPM 
mean inhale amplitude. This may indicate the unpredictability of amplitude-based 
gating for patients with compromised lung function; however more volunteer and 
patient breathing tracks would be required to test the hypothesis. 
 
In amplitude-based gating the large intra-fraction variation demonstrated by 
these patients would result in constant beam off and re-tracking, both of which 
increase patient treatment times and discomfort, and decrease patient 
throughput.  
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Figure 4.22 Intra-fraction RPM mean inhale amplitude for each patient. 
 
4.5.3 RPM: Frequency 
Patients 2 and 3 show very little intra- and inter-fraction variation in the breathing 
frequency as illustrated in Figure 4.23. Patients 1, 4, 6 and 7 show large intra- 
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and inter-fraction variation in most fractions, with patient 1 showing the largest 
inter-fraction variation. 
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Figure 4.23 Intra- and inter-fraction RPM breathing frequency for each patient. 
 
As mentioned earlier, faster breathing rates will correspondingly trigger the 
beam-off and -on function more frequently, irrespective of amplitude- or phase-
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based gating approaches. This results in smaller amounts of radiation being 
delivered each time the beam is triggered on, which will increase the treatment 
time and furthermore, increases the risk of inaccurate dose delivery as the 
radiation beam is not linear in the smaller range. 
 
Patients 2 and 3 may be more suitable for amplitude- or phase-based gating due 
to their intra- and inter-fraction reproducibility. The remaining patients would be 
less suitable candidates for gating without further audio and/or visual coaching.  
 
4.5.4 RPM: Asymmetry 
The asymmetry intra- and inter-fraction variation is large for all patients, as seen 
in Figure 4.24. The intra-fraction variation is particularly large for patients 1, 4 
and 8. The breathing waveforms are not very symmetrical for all patients, with 
the exception of patient 7 who has symmetry close to a perfect 0.5.  
 
Patient 7 would be a more suitable candidate for phase-based gating based on 
the absolute value of symmetry. Large asymmetry is not suitable for phase-
based gating due to the irregularities from one breathing cycle to the next.  
 
However the large intra- and inter-fraction reproducibility for all patients would 
result in the radiation beam turning on and off erratically in a phased-based 
gating regimen. Further audio and/or visual coaching may assist the patients in 
enhancing the reproducibility of the breathing symmetry. 
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Figure 4.24 Intra- and inter-fraction RPM asymmetry for each patient. 
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4.5.5 RPM: Relative Inhale Duty Cycle 
The relative inhale duty cycle for the patients show large intra- and inter-fraction 
error bars, similar to the volunteer results. The fluctuations in the relative inhale 
duty cycle observed in Figure 4.25 are not significant. 
 
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
Cy
cl
e
 
(%
)
P1
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
C
yc
le
 
(%
)
P2
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
Cy
cl
e
 
(%
)
P3
 
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
Cy
cl
e
 
(%
)
P4
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
C
yc
le
 
(%
)
P5
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
C
yc
le
 
(%
)
P6
 
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
C
yc
le
 
(%
)
P7
-20
0
20
40
60
80
100
120
1 2 3 4 5 6 7 INTER
Fraction
R
e
la
tiv
e
 
In
ha
le
 
D
u
ty
 
Cy
cl
e
 
(%
)
P8
-20
0
20
40
60
80
100
120
P1 P2 P3 P4 P5 P6 P7 P8
Patient
Re
la
tiv
e
 
In
ha
le
 
D
u
ty
 
Cy
cl
e
 
(%
)
 
 
Figure 4.25 Intra- and inter-fraction RPM mean relative inhale duty cycle for each patient. 
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4.5.6 RPM: Relative Exhale Duty Cycle 
Similar to the relative inhale duty cycle, the fluctuations in the relative exhale duty 
cycle observed in Figure 4.26 are not significant. 
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Figure 4.26 Intra- and inter-fraction RPM mean relative exhale duty cycle for each patient. 
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The large error bars are a result of combing the standard deviations of the 
frequency and absolute duty cycle times as calculated by the software. Given 
that the size of the error bars render the fluctuations in value of the relative duty 
cycle insignificant, the relative duty cycle, as calculated in this study, is not a 
sensitive parameter. 
 
The values of relative exhale duty cycle for the patients are generally more 
reproducible than the relative inhale duty cycle; this is consistent with the study 
by Vedam et al.,64 which found that the exhale phase was more reproducible 
than inhale, and is also consistent with the volunteer RPM results. 
 
4.6 COMPARISON BETWEEN REAL TIME POSITION MANAGEMENT AND SPIROMETRY 
In this study two methods of breathing surrogates were used for the volunteer 
breathing track acquisitions: spirometry and RPM. Studies have shown the 
relationship between the two methods by correlating the breathing waveforms. 
Using 4DCT in conjunction with abdominal height displacement and spirometry 
on 5 patients, Lu et al. achieved correlation coefficients greater than 0.98 
between abdominal height and spirometry after accounting for a time offset.69 Lu 
et al. also found that RPM displacement led spirometry change with a mean of 
0.12 s per cycle. 
 
The advantage of a high correlation between the two surrogates is the 
interchangeability of equipment. Those centres which have already invested in or 
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are considering the purchase or replacement of one type of gating system may 
achieve the same results without a change in protocol and procedures, 
regardless of equipment.  
 
Furthermore, spirometry is often viewed as a more fundamental measure than 
RPM as it quantifies a physiological metric,69 and demonstrates a higher 
correlation with tumour motion than an external abdominal marker.66 A high 
correlation between spirometry and RPM would justify the use of either system.  
 
Given the time offset between spirometry and RPM, however, the two methods 
cannot be used interchangeably from 4DCT scanning to treatment as there is a 
unique relationship to the internal tumour motion for each surrogate. It is 
therefore critical that the surrogate used during the 4DCT scanning procedure is 
also used during the patient’s gated radiotherapy treatment. 
 
4.6.1 Correlation between waveforms 
The breathing waveforms from fraction 4 (the 5 min fraction) for the 3 volunteers 
were correlated in Matlab with a time offset for each breathing cycle, similar to 
the work of Lu et al.69 The overlaid spirometry and RPM breathing waveforms are 
presented in Figure 4.27 to Figure 4.29 for the 3 volunteers, each showing the 
pre and post time offset correction. The waveforms have been scaled by dividing 
the waveform by the maximum value for ease of comparison. 
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Due to the different sampling rates for spirometry and RPM, the raw data was re-
sampled and interpolated to achieve the same number of data points over a 
given period at the same points in time for both methods.  
 
A correlation coefficient was calculated for each waveform pair pre and post time 
offset correction. The results are presented in Table 4.1. The correlation 
coefficients for the time corrected waveforms are consistent with those reported 
by Lu et al.69 The slightly lower value for volunteer 2 can be explained by the 
initial 50 s of the breathing waveform (see Figure 4.28), where the RPM 
waveform demonstrates inconsistent behaviour with the remaining 250 s. It must 
be noted that the amplitude in the raw data is significantly smaller for the RPM 
waveform, contributing to the lower degree of correlation.  
 
Table 4.1 Correlation coefficients for all volunteers, pre and post time offset. 
Volunteer Correlation Coefficient 
Post time offset 
1 0.99 
2 0.92 
3 0.98 
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Figure 4.27 Volunteer 1 spirometry and RPM correlation: pre and post time offset correction. 
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Figure 4.28 Volunteer 2 spirometry and RPM correlation: pre and post time offset correction. 
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Figure 4.29 Volunteer 3 spirometry and RPM correlation: pre and post time offset correction. 
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4.6.2 Correlation between parameters 
As mentioned earlier, in order to determine the time offset the raw waveforms 
were re-sampled and interpolated. Thus the parameter correlations between 
RPM and spirometry were performed on the parameters calculated from the 
original (uncorrected for time offset) waveforms, allowing for a true correlation of 
the calculated parameters.  
 
The correlation between RPM and spirometry was calculated for frequency and 
asymmetry only. As the mean cyclic baseline was not referenced to an external 
marker, the absolute values are not useful hence any attempts at correlating with 
an absolute volume from spirometry are meaningless. Similarly, the amplitude in 
cm cannot be meaningfully correlated with the spirometric amplitude in ml. 
 
The running mean of the frequency and asymmetry parameters, as calculated 
from fraction 4 (the 5 min fraction) was used as it provided the largest amount of 
data for comparison. The relative inhale and exhale duty cycles were not 
included in this comparison as they require additional processing from the values 
given by the software; the uneven lengths of data between frequency and duty 
cycle, required to calculate relative duty cycle, presented difficulties in correlating 
the data. 
 
The data from all volunteers was combined for each parameter to create a global 
data set. A simple linear regression was used to test for the existence of 
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equivalence between the two techniques, by testing whether the slope is 1 and 
intercept is 0. The results are reported as the slope and intercept of the line of 
best fit with corresponding p-values, and the R2 value. The correlation coefficient 
was also calculated using an MS Excel function. 
 
The p-value for the intercept tests if the intercept is significantly different from 0, 
indicated with a p-value less than 0.05. An R2 value greater than 70% indicates a 
strong relationship between spirometry and RPM for that parameter. 
 
Table 4.2 Regression analysis for correlation between spirometry and RPM for frequency and 
asymmetry. 
Parameter Volunteer Correlation 
Coefficient 
Slope p-value 
slope 
Intercept p-value 
intercept 
R2 
(%) 
Frequency Global 0.98 0.94 0.00 0.45 0.03 97 
Asymmetry Global 0.95 0.94 0.00 0.02 0.01 92 
 
The results of the linear regression for the four parameters are presented in 
Table 4.2.  It can be seen that the slope is significantly different from 1, and the 
intercept is significantly different from 0, for both parameters.  
 
Frequency 
The global correlation in Figure 4.30 shows a good relationship between 
spirometry and RPM for frequency an R2 of 97% and correlation coefficient of 
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0.98. This indicates that RPM may be used interchangeably with spirometry to 
determine the frequency of breathing from a breathing track. 
 
Whilst frequency is expected to exhibit a near perfect correlation between 
spirometry and RPM, this is not the case in practice. The two breathing tracks 
are matched at the end of the time period by manually switching both the 
spirometer and RPM off simultaneously. The two tracks are then aligned 
backwards, which may result in one track having an extra breathing cycle or half 
a breathing cycle, offsetting the frequency count. 
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Figure 4.30 Global correlation between spirometry and RPM for frequency with fitted line. 
 
Asymmetry 
Figure 4.31 shows a good relationship between spirometry and RPM for 
asymmetry with a correlation coefficient of 0.95 and an R2 of 92%. This indicates 
 115 
that RPM may be used interchangeable with spirometry to determine asymmetry 
of the breathing track, or vice versa.  
 
ALL V
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.0 0.2 0.4 0.6 0.8
Spirometry
R
PM
 
Figure 4.31 Global correlation between spirometry and RPM for asymmetry with fitted line. 
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5 Discussion  
Respiratory gated radiation therapy is dependent upon the intra- and inter-
fractional reproducibility of the breathing motion,31,52,66,72-73 and on the correlation 
between the internal tumour motion and an internal or external surrogate for 
motion. Numerous studies have addressed the surrogate/internal motion 
correlation with varying degrees of correlation.5,11,52,55,64  
 
Previous studies have attempted to model the breathing waveform in order to 
improve the efficiency and accuracy of respiratory gated treatment.38,76 It is 
difficult to predict a random occurrence or breathing pattern, hence the models 
are not viable for patients who cannot maintain intra- and inter-fraction 
reproducibility. Kini et al73 found that uncoached patients showed poor 
reproducibility in the frequency and amplitude of their breathing waveform.  
 
Considering that respiratory gated radiotherapy requires longer treatment times 
and patient co-operation, a method to pre-select patients who are able to 
reproduce the breathing waveform both intra- and inter-fraction, would assist in 
the efficient use of a department’s resources and minimise patient discomfort. 
 
There exist many different technologies for respiratory gating, as described in 
Chapter 1: Introduction and Literature Review, therefore criteria for patient 
selection must encompass the characteristics pertinent to each technique. 
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This study focused on characterising the breathing waveform, with the aim of 
quantifying those parameters that described the waveform to provide information 
relevant to several of the respiratory gating techniques commercially available. 
Ruan et al79 developed a method to profile the respiratory motion in real time by 
calculating the baseline drift, frequency variation and fundamental pattern 
change. Each of these parameters was chosen as a characteristic of respiratory 
motion, with “distinct physiological interpretation and clinical consequences”.79 
 
For the current study, these three parameters were interpreted as: the mean 
cyclic baseline, frequency and asymmetry of the breathing waveform. In addition, 
the mean amplitude was identified as a quantifiable characteristic of the 
breathing waveform and the mean inhale and exhale duty cycle was also 
calculated and referenced to the frequency of breathing, resulting in a relative 
duty cycle. The emphasis was on intra- and inter-fraction reproducibility, as 
described by the standard deviation.  
 
Whilst it is possible to manually calculate these parameters, the task becomes 
time consuming for any significant quantity of breathing tracks. A software tool 
was therefore developed in MatLab to more efficiently quantify the characteristics 
of breathing waveforms acquired using external surrogates for motion. Post-
processing was achieved using MS Excel. The software was designed to accept 
input from any form of external motion surrogates, however only two methods 
were tested for this study: spirometry and RPM.  
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For some parameters, there is a large variation between the 1 min fractions 
compared with the 5 min fraction. This is consistent with the report by von 
Siebenthal et al. which examined the correlation between internal and external 
motion over tens of minutes using time resolved MRI volumes on 12 healthy 
volunteers. von Siebenthal et al. concluded that whilst a short term (30 s to 3 
min) breathing track was suitable for 4DCT, a longer term analysis of intra-
fraction motion is required for IGRT.32 
 
NØttrup et al. caution that treatment planning based on one 4DCT session alone 
is not sufficient, citing inter-fraction variations in exhale up to 10 times larger than 
intra-fraction variations when using Varian’s RPM system in conjunction with an 
in-house developed infrared reference marker on 11 patients with loco-regional 
lung cancer.74  
 
The following results confirm that some parameters are not reliably reproducible 
from fraction to fraction, highlighting the need for respiratory correlated imaging 
in order to reduce the geometrical uncertainties arising from irregularities in the 
breathing waveform93 and to compensate for variations from the 4DCT planning 
session to the planned course of radiotherapy treatment.29,74 In general, intra-
fraction variations are smaller than inter-fraction variations. Hence respiratory 
gated radiotherapy treatments that are planned from a single 4DCT simulation 
planning session may result in a geographical miss of the tumour, and potentially 
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deliver increased dose to critical organs and normal tissue surrounding the 
tumour.  
 
A geographical miss may be minimised with the use of respiratory correlated 
cone beam CT imaging on the linac at the time of treatment, although random 
intra-fraction variations cannot be detected in this manner.93 Whilst the definition 
of random variations precludes and defies predictive modeling, implementing the 
following criteria can assist in determining those patients who may be more 
suitable for respiratory gated treatments or benefit from audio visual coaching.  
 
5.1 EVALUATION OF PARAMETERS 
From the results presented in Chapter 4: Results, it can be seen that not all 
patients behave in the same manner for all parameters. Radiotherapy centres 
that apply a population-based approach to gated treatment may find the patient is 
not suitable for that particular treatment delivery or gating window, resulting in 
large residual motion, inefficient use of resources and patient discomfort.  
 
5.1.1 Cyclic Baseline 
The baseline of a breathing waveform may be affected by physiological or 
mechanical variations. Drifts in the baseline have been reported for the tumour 
position,11,32,45 spirometry23,66 and RPM.11  
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Baseline drift in spirometry can be attributed to several sources, depending on 
the type of spirometer used. Turbine based spirometers exhibit drift due to large 
differences between ambient and cylinder air temperatures, imbalances between 
the electronics and mechanical blade, and flow rate changes.23 The flow 
spirometer used in this study was calibrated over different flow rates to ensure 
linearity. It was also programmed to re-zero the baseline after every breathing 
cycle, similar to Elekta’s Active Breathing Control system.23 Whilst this 
overcomes baseline drift due to leakage, it affects the true volume difference 
between inhale and exhale, as discussed in the next section Amplitude.  
 
Significant baseline drift can result in negative effects such as the radiation beam 
not turning on or turning on in the wrong phase. In cases of significant baseline 
drift the respiratory signal must be re-tracked, which in turn results in an 
increased treatment time. The variation in the cyclical baseline is therefore an 
indication of the baseline shift and is the parameter of interest in patient selection 
for gated respiratory treatment. 
 
Rapid or constant fluctuations in the baseline are not suitable for respiratory 
gated radiotherapy, as this implies the patient is not able to maintain a stable and 
reproducible waveform. Ruan et al79 used the baseline drift as an indication of 
abrupt movement requiring intervention in the form of treatment interruption or re-
adjustment.  
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As mentioned previously, an ideal breathing waveform would exhibit inhale and 
exhale functions which rise and fall about a mean point that remains stable 
throughout the entire time period under investigation. From the patient data 
acquired with RPM for this study very little intra-fraction variation was seen, 
although there was large inter-fraction variation in cyclic baseline. The volunteers 
likewise showed very little intra-fraction variation for both spirometry and RPM, 
and large inter-fraction variation. 
 
Although the inter-fraction variation is large it is not of concern as the baseline 
was not referenced to a fixed external marker. Also the absolute position of the 
cyclic baseline is not of interest in itself; rather the variation in cyclic baseline 
within each fraction is the quantity of interest. The patient and volunteer results 
indicate that the mean position of the breathing waveform remains stable 
throughout each fraction. This highlights Ruan et al’s conclusion that abrupt 
changes in the baseline require treatment interruption or adjustment as a stable 
baseline is to be expected.79 
 
In this study, the baseline was determined by averaging the maximum point of 
inhale and exhale for each breathing cycle. This method of calculating the 
baseline is not consistent with other published techniques, such as the work by 
Nishioka et al94 where the baseline was determined and applied to the most 
stable portion of the breathing track, rather than each individual breathing cycle.  
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Nishioka et al were able to select a more stable portion of the breathing track by 
observing the patient for 5 min prior to establishing a baseline. They found that 
the baseline position became more reproducible in the later part of the 5 min 
observation.94 For the current work, the 2 min patient breathing tracks were 
generally insufficient to establish a stable end point. Furthermore any upwards or 
downwards trends in the breathing track, referred to as drifts in the baseline, 
were difficult to account for in the software. 
 
Hence the mean cyclic baseline was established in this investigation as it is more 
robust in the presence of drift and other influences on the signal and would be an 
advantageous optional feature in future gating devices. 
 
5.1.2 Amplitude 
Radiotherapy centres may opt for amplitude based gating, with population based 
gating windows. However, not all patients are able to maintain a reproducible 
breathing amplitude throughout one fraction, or across many treatment fractions.  
 
From the patient results, the large intra-fraction variations indicate that a 
population based approach using amplitude based gating would not be 
appropriate for these patients, as the intra-fraction variation would require 
constant interruption and re-tracking of the gating signal. 
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Patients 2, 4 and 7 show a wide range of values from fraction to fraction, with 
correspondingly large inter-fraction variation. They also exhibited large intra-
fraction variation, rendering them unsuitable for amplitude-based gating without 
further audio-visual coaching. Patient 3, however, demonstrated reproducible 
values intra- and inter-fraction, indicating suitability for amplitude-based gating.  
 
Fuji et al7 found that an individualised approach for each patient resulted in more 
precise and efficient gated treatment delivery. A population based approach is 
not recommended as large residual motion, the respiratory motion that continues 
within the gating window for a given breathing cycle, may result, reducing the 
effectiveness of gated treatment delivery.94-95 Therefore, the intra- and inter-
fraction variation in the mean amplitude for each patient is of interest when 
determining whether or not to apply an amplitude based gating regimen. 
 
As mentioned in the previous section 5.1.1 Cyclic Baseline, the method of 
calculating the baseline results in the maximum inhale and exhale volume (in the 
case of spirometry), or amplitude (in the case of RPM), falling symmetrically 
about the cyclic baseline.  
 
This method of determining the amplitude is not consistent with other techniques 
reported in the literature, such as Vedam et al,64 who stated that the point of 
exhale was the most stable and the point of inhale provided the greatest lung 
volume. Determining the amplitude using the method described in section 3.3.4 
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Amplitude will not demonstrate this behaviour. It is important to note that the 
RPM system determines amplitude as per the work of Vedam et al. 
 
 
 
Figure 5.1 Amplitude determined by a moving baseline, ensuring equal areas under the curve for 
inhale and exhale amplitudes (solid line), and amplitude as determined by a global mean baseline 
(dashed line), resulting in misleading values for inhale and exhale amplitudes. 
 
However the quantity of interest for the mean amplitude, as calculated in this 
study, is the reproducibility in relation to the cyclic baseline. The baseline itself is 
of interest as a selection criterion, and the mean amplitude as calculated in this 
study is a function of the cyclic baseline.  
 
The more common approach of zeroing the breathing cycle about a global mean 
baseline would nullify the effects of baseline drift and potentially result in 
misleading values for the inhale and exhale amplitudes (Figure 5.1). 
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5.1.3 Frequency 
Ruan et al79 reported that significant variations in the breathing frequency 
indicated an irregularity requiring clinical attention. A patient who breathes with a 
high frequency per minute may not be suitable for gated radiotherapy as the 
radiation beam would be gated on and off at highly frequent intervals. From a 
dosimetric perspective, this is undesirable for the necessarily smaller radiation 
output as an overdosage may result due to the ramping up effect of the radiation 
beam.96 
 
Some patients showed very little intra- and inter-fraction variation in the breathing 
frequency, such as patients 2 and 3, whereas others showed very large variation, 
such as patients 1 and 6. Those patients with a large intra-fraction variation will 
not be suitable for phase or amplitude based gating, as the beam on/off trigger 
would be irregular and abrupt.  
 
The uncoached breathing frequency recorded at the first fraction does not 
generally appear to be a predictor for future treatment; this is indicated by the 
large inter-fraction variation for most patients. This is further reinforced by the 
difference in the intra-fraction variation in fraction 1 compared with subsequent 
fractions for many of the patients.  
 
Several factors may contribute to the variation between the first fraction and 
subsequent factors that may be directly related to the patient and/or the 
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equipment; such as the patient relaxing over time as they become familiar with 
the technique, or equipment drifts with time. In the case of the patient relaxing 
over subsequent fractions, allowing time to become familiar with the equipment 
and technique prior to the initial 4DCT scan may assist in ensuring the first scan 
is indicative of the patient’s breathing pattern. In the case of equipment drift, an 
understanding of the equipment drift pattern over time would ensure an adequate 
calibration and quality assurance program is implemented, or appropriate 
compensation factors used. 
 
5.1.4 Asymmetry 
Gated treatment that has been planned from an initial 4DCT scan assumes 
reproducibility in the respiratory and target motion during the scan and 
consequent treatment delivery. However, as mentioned in the previous section, 
various human or equipment factors may affect the reproducibility between the 
initial 4DCT scan and subsequent treatment fractions. NØttrup et al74 have shown 
that inter-fraction variations must be considered when delivering gated treatment 
based on a 4DCT scan. Ruan et al79 propose that the fundamental pattern of the 
breathing waveform, calculated in this study as the asymmetry, can be used to 
validate the consistency between a planning 4DCT scan and gated treatment 
delivery. 
 
 
The method used in this study to quantify asymmetry does not take amplitude 
into account. Similar to Varian’s software, the asymmetry is quantified here as a 
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function of time, hence it is a valuable metric when considering phase based 
gating. Rapid or delayed changes from one phase to the next may preclude the 
patient from phase based gated treatment. This parameter is also applicable in 
4DCT scans, where irregular breathing patterns may not only prolong the time of 
acquisition but also result in acquisitions during the wrong phase of the breathing 
cycle or image artifacts.2  
 
The patient breathing waveforms show significant symmetrical consistency in the 
inter-fraction values when compared with other patients. This indicates that 
phase based gating is more appropriate if a department is considering a 
population based approach to gated treatment. 
 
5.1.5 Relative Duty Cycle 
The relative duty cycle describes the amount of time spent within 20% of the 
maximum inhale or exhale amplitudes, divided by the number of breaths per 
second. This should not be confused with the more common definition of duty 
cycle, which is the ratio of the beam on time to the total treatment time.2,64 The 
duty cycle, as calculated in this investigation, was intended as a substitute prior 
to treatment and is not intended as a patient selection criteria. 
 
Smaller duty cycles improve the accuracy of gated treatment delivery due to the 
resulting decrease in residual motion; however this is counteracted by the longer 
treatment times required and the potential for geometric misalignment due to 
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patient movement. George et al. suggest implementing duty cycles of 30% - 50% 
as a compromise between treatment efficiency and minimisation of residual 
motion within the gating window.11 
 
The method of calculating relative duty cycle in this study resulted in very large 
intra- and interfractional error bars for all patients and volunteers. Given the size 
of the error bars, any fluctuations in the relative in- and exhale duty cycles are 
insignificant, hence this particular parameter is not a sensitive indicator of the 
true duty cycle. 
 
5.1.6 Comparison Between Real Time Position Management and 
Spirometry 
Lu et al69 found that spirometry height correlated well with RPM displacement 
(>0.98) under free breathing. In order to maximize the correlation, Lu et al 
applied a time offset to the spirometry volume waveform in order to match the 
abdominal height displacement waveform. The time offset showed that 
abdominal height change always led the spirometry volume change. 
 
This was not always observed in the current study; in some cases the volume 
change led the displacement change. The difference in findings can be attributed 
to the different location of the RPM marker in this study and the variation in 
breathing between individuals, some of whom are chest driven breathers as 
opposed to abdominal driven.69 
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In this study, the correlation between spirometry and RPM was investigated for 
two parameters: asymmetry and breathing frequency. Asymmetry and breathing 
frequency correlated well. 
 
Breathing frequency was expected to be highly correlated between spirometry 
and RPM due to the absolute nature of this parameter. A low degree of 
correlation would indicate failure of the software. Likewise asymmetry, which was 
calculated as a function of time, was expected to be highly correlated.  
 
The cyclic baseline was not expected to correlate well due to the differences in 
units and a lack of external reference points, hence was excluded from the 
correlation analysis. Similarly, as the amplitude was derived from the cyclic 
baseline in the algorithm used in this study, the amplitude correlation between 
spirometry and RPM was also excluded. 
 
From the two parameters investigated in the correlation analysis, as well as the 
high degree of correlation between the breathing waveform patterns, it can be 
concluded that spirometry may replace or be considered equivalent to RPM (and 
vice versa) when using these parameters to determine patient suitability for gated 
treatment. 
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5.2 USING THE PARAMETERS IN PATIENT SELECTION FOR RESPIRATORY GATED 
RADIOTHERAPY 
It is difficult to define a quantitative limit at which a patient would or would not be 
suitable for amplitude or phase-based gating. Several factors must be considered 
in conjunction with the parameters defined in this study; each centre 
implementing a respiratory gated treatment program must also consider the 
acceptable margins around the treatment volume; treatment time tolerance for 
beam on/off or re-tracking and corresponding decrease in patient throughput; an 
individual patient’s tolerance for discomfort and ability to remain immobile for the 
length of treatment; and the technological limits of the gating and beam delivery 
equipment in terms of drift, system latency and accuracy of radiation dose 
delivery in small increments. 
 
Those centres considering a population based approach should be aware that 
amplitude shows greater variation in reproducibility than asymmetry, hence a 
phase-based approach would be more appropriate. However some patients 
exhibited small variation in amplitude and may be considered for amplitude 
based gating in an individualised setting. Berbeco et al. found that 5 out of 8 lung 
cancer patients treated using Mitsubishi’s RTRT system displayed less residual 
motion in amplitude based gating compared with phase based gating.97 
 
Furthermore treatment plans or regimens based on the first fraction, or data 
acquisition at 4DCT, should be used with caution as the results indicate that this 
data is generally not predictive of future behaviour in uncoached patients. This 
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correlates with the findings of NØttrup et al,74 who states that planning cannot be 
safely based on the data from a single session, and Sonke et al.93 who 
recommend the use of image guided radiation therapy using a cone beam CT on 
the linac just prior to treatment. 
 
5.3 LIMITATIONS 
The breathing waveforms acquired for analysis in this study were obtained from 3 
volunteers in good health using Varian’s RPM gating system and a customised 
spirometer simultaneously, and 8 patients enrolled in an ethics approved study 
using RPM only. The volunteer data were acquired on 4 separate occasions: 3 
fractions of 1 min duration and a fourth fraction of 5 min duration. The patient 
data were acquired over several fractions with varying duration.  
 
This study was limited by the small cohort of volunteers and patients, and 
breathing tracks from only a few fractions. The breathing tracks, whilst longer 
than many published results, were not long enough to provide information over a 
typical treatment time. Hosiak et al. recommend the acquisition of measurements 
over a typical treatment time66 of 10 – 15 min.69 
 
There were inherent uncertainties in the data acquisition from the volunteers and 
patients, as well the spirometer and RPM. The software also imposed some 
limitations in data processing. 
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5.3.1 Spirometer 
Spirometry has been reported to exhibit a signal drift over time,23,69 hence the 
customised spirometer used in this study was programmed to automatically re-
zero the signal after each exhale. Elekta’s Active Breathing Control (ABC) also 
corrects for signal drift by re-zeroing the signal baseline at the start of every 
breath cycle. The disadvantage of this method is the risk of nullifying the true 
difference between the exhale and inhale volumes.23 For this study, the algorithm 
used to determine the cyclic baseline parameter assumes a symmetrical 
distribution of volume between inhale and exhale, allowing reproducibility of the 
volume, relative to the cyclic baseline, to be calculated. 
 
5.3.2 RPM 
Reproducible placement of the reflective marker on the patient is difficult to 
achieve. The largest displacement of the marker has been observed when 
positioned at the abdomen or xiphoid,66,98 allowing easier visualisation of the 
marker excursion.  
 
The volunteers underwent RPM with the marker near the xiphoid process. 
However inter-fractional reproducibility was difficult due to the lack of a 
permanent marker on the volunteer’s skin surface. Whilst position of the marker 
relative to the bony anatomy was recorded, the marker had to be repositioned on 
a few occasions as it was not visible to the detector. This phenomenon has been 
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reported by Killoran et al.98 and poses an obstacle to accurate inter-fractional 
reproducibility for parameters such as baseline. 
 
5.3.3 Patients and Volunteers 
Each volunteer was asked to arrive 5 min prior to data acquisition to sit quietly in 
order to maintain a physical baseline. In addition, the volunteers were selected 
for their similarity in age and physical condition.  
 
This was not possible to achieve with the patients, as the data was provided from 
an ethics approved study not directly related to this study. Hence it is unknown 
whether the patient data were acquired under the same conditions for each 
patient for all fractions.  
 
5.3.4 Software 
The software originally calculated a global mean baseline, which was applied to 
derive the inhale and exhale amplitudes. Due to intra-fraction baseline drift, the 
software was unable to process several patient files. The mean cyclic baseline 
was developed in order to bypass this limitation. This is discussed in more depth 
in section 3.3.3 Cyclic Baseline. 
 
Despite the new algorithm, some patient files were not able to be processed as 
they contained spurious data or too few breathing cycles. It was found that a 
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minimum of 4 breathing cycles were required to accurately compute the 
parameters. 
 
5.4 FUTURE WORK 
Future work will involve more detailed investigation of the inter-fractional 
reproducibility, as well as testing the software for further applications. 
 
The small cohort of volunteers and patients used in this study are not sufficient to 
definitively produce a protocol for patient selection. The acquisition of more 
breathing tracks over a longer time period for each fraction (in the order of 15 min 
to coincide with a typical treatment time69) would allow a more comprehensive 
testing and provide a greater volume of data for statistical analysis. 
 
There have been many studies published on the effectiveness of audio and/or 
visual coaching on intra- and inter-fractional reproducibility of the breathing 
waveform.11,67,75 However, in order to develop criteria from which to select 
patients for respiratory gated radiotherapy an initial triage is required before 
expending resources, causing discomfort to, or mis-treating a patient who is not 
suitable for this specialised treatment delivery. Hence for this study, all breathing 
tracks acquired were from uncoached volunteers and patients. Whilst some 
waveforms showed trends over time as the volunteer or patient relaxed and/or 
became familiar with the process, formal coaching was not given.  
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For those patients who are given audiovisual feedback coaching, the software 
may be used to quantify the effectiveness of coaching. Future work would involve 
testing the software for this application by acquiring pre- and post-coaching 
breathing tracks in 15 min time segments from the same individual, and 
quantitatively assessing each parameter. 15 min is a typical treatment time, and 
would better depict the breathing waveform over the entire treatment process. 
 
Multiple pre- and post-coaching breathing tracks would be required to assess the 
reproducibility of audio-visual coaching with statistical significance. The success 
of coaching may be quantified by small intra- and inter-fraction variations in each 
parameter for the same patient post-coaching, compared with pre-coaching 
variations. 
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6 CONCLUSIONS 
Respiratory gated radiotherapy is used as a motion management technique in 
external beam radiation therapy for cancers of the liver, lung and breast. The 
technique requires the patient to breathe in a regular, reproducible pattern. This 
is difficult for those patients with compromised respiratory function.  
 
To minimise patient discomfort during treatment and avoid the inefficient use of 
time and resources, a software tool was developed to triage patients prior to 
4DCT and gated radiotherapy. This tool quantifies the variations in a patient’s 
breathing pattern, assisting the clinician in the decision to proceed to 4DCT 
simulation for treatment planning, and gated treatment.  
 
Many non-invasive surrogates for respiratory motion have been developed due to 
the risk of pneumothrorax associated with the insertion of fiducial markers into 
the lungs. Motion surrogates include Varian’s Real Time Position Management 
system (RPM), spirometry and pressure sensors. 
 
A software tool was developed in MatLab using breathing tracks from volunteers 
and patients as input data. The volunteers were comprised of 3 non-smoking 
males of similar age and level of health. Breathing tracks for the volunteers were 
acquired using the RPM and spirometer simultaneously for 60 s on three 
separate fractions, and for 300 s on one fraction.  
 
Breathing tracks for 9 patients were acquired from an ethics approved study at 
the Peter MacCallum Cancer Centre in Melbourne, Australia. Patient data were 
 137 
acquired using only the RPM system over 3 to 7 fractions. The patient breathing 
tracks varied in length from 45 s up to 300 s. Of the 10 patients considered, only 
8 patients were able to be analysed with the software due to extreme 
irregularities in the breathing patterns.  
 
The software is based on a series of algorithms and allows the user to input data, 
specify the sampling rate and filter level. The data, in the form of breathing 
waveforms, is processed depending on the input format. Whilst the RPM system 
and a customised spirometer were used as input data in this investigation, the 
software has been designed to easily adapt to other forms of respiratory motion 
surrogates, such as a pressure belt.  
 
The software then calculates several parameters and presents the output in 
graphical and numerical form, which may be exported to MS Excel for ease of 
post-processing data manipulation.  
 
Five parameters were established to quantify a breathing pattern; these are: 
• Mean cyclic baseline: the mean point between exhale and inhale for each 
breathing cycle; 
• Inhale and exhale amplitude: the maximum point of inhale and exhale for 
each breathing cycle as indicated by the maximum volume or displacement 
recorded by the spirometer and RPM respectively; 
• Frequency of breathing: number of breaths, or inhale and exhale cycles, 
recorded over a given time frame;  
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• Asymmetry of the breathing pattern: the regularity of each breathing cycle; 
and 
• Relative inhale and exhale duty cycle, being the typical amount of time spent 
within 20% of the maximum inhale or exhale amplitudes for each breathing 
cycle divided by the frequency of breathing. This was used as a substitute for 
the true duty cycle, which is the ratio of the radiation beam on to beam off 
time. 
 
Using the standard deviation, the variations in each parameter were quantified as 
a measure of reproducibility both inter- and intra-fraction. 
 
Intra-fraction reproducibility indicates the patient’s ability to maintain the 
breathing pattern within each fraction, which is essential for gated radiotherapy. 
Inter-fraction reproducibility is an indication of whether a 4DCT and delineation of 
an internal target volume is representative of the patient’s breathing pattern 
throughout a course of radiotherapy. It is also an indication of the patient’s ability 
to maintain a reproducible breathing pattern throughout the course of treatment. 
 
Analysing breathing patterns from the 3 volunteers and 8 patients clearly indicate 
that some patients are not suited to amplitude based gating due to the irregularity 
of their breathing amplitude. Similarly, rapid or irregular phase changes may 
preclude the patient from phase based gating.  
 
The results also show that uncoached breathing amplitudes are not generally 
reproducible for both the healthy volunteers and lung cancer patients, hence 
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phase based gating regimens are recommended when considering a population-
based approach to respiratory managed radiation treatments. 
 
As expected, the volunteers’ breathing frequency was much lower and showed 
greater reproducibility than the patients, as well as better symmetry.  
 
The results indicate that intra-fraction variations are generally smaller than inter-
fraction variations. This confirms the findings in published literature, which 
recommend the use of respiratory correlated image guidance at the time of 
treatment in conjunction with respiratory gating.  
 
Radiotherapy centres performing or considering motion management techniques 
would benefit from the use of this software to triage or coach patients; it would 
also be useful as a training tool for staff. The software is simple to implement and 
requires only the acquisition of a breathing pattern using any motion surrogate, 
allowing prospective patients to be quickly and quantitatively assessed for 
progression to motion management. The choice of parameters used to quantify 
the patient’s suitability would be dictated by the motion management techniques 
used by the centre, and tolerance for extended treatment times. 
 
Numerous studies have shown that audio and/or visual coaching may assist the 
patient in maintaining a more regular and reproducible breathing pattern. The 
software could also be used to process the results of respiratory coaching by 
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comparison of these parameters, allowing the effectiveness of coaching to be 
quantified. Future work will involve testing the software using pre- and post-
coaching patient data. 
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